{"gene":"HES1","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1999,"finding":"Hes1 and Hes5 are essential downstream effectors of Notch signaling in mammalian neuronal differentiation; constitutively active Notch fails to inhibit neuronal differentiation in Hes1/Hes5 double-null neural precursor cells, placing Hes1 genetically downstream of Notch in this pathway.","method":"Retroviral misexpression of constitutively active Notch in wild-type, Hes1-null, Hes5-null, and Hes1/Hes5 double-null mouse neural precursor cells; genetic epistasis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic epistasis with double-null rescue, replicated across multiple genotypes in a single rigorous study","pmids":["10205173"],"is_preprint":false},{"year":1998,"finding":"Delta-1 activation of Notch-1 results in transcriptional upregulation of HES-1; this transactivation requires both Kuzbanian metalloprotease activity and RBP-J (CSL) transcription factor activity, placing HES-1 as a direct transcriptional target downstream of the Delta-1/Notch-1/RBP-J axis.","method":"Two-cell coculture assay with Notch-1-expressing cells and Delta-1-expressing cells; HES-1 promoter-luciferase reporter; endogenous HES-1 mRNA measurement; dominant-negative Kuzbanian and RBP-J inhibition","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (reporter assay, endogenous mRNA, genetic inhibition of pathway components) in one study","pmids":["9819428"],"is_preprint":false},{"year":2000,"finding":"Hes1 deficiency in mice causes depletion of pancreatic epithelial precursors through accelerated differentiation into endocrine cells, with upregulation of multiple bHLH proneural/endocrine factors, establishing Hes1 as a general negative regulator of endodermal endocrine differentiation that keeps precursor cells undifferentiated.","method":"Hes1 knockout mouse analysis; histology; expression analysis of bHLH components in pancreas, stomach and gut","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean loss-of-function mouse model with defined cellular phenotype, replicated across multiple tissue types","pmids":["10615124"],"is_preprint":false},{"year":2000,"finding":"Hes6 suppresses Hes1 transcriptional repression without itself binding DNA; Hes6 also relieves Hes1-mediated inhibition of Mash1-E47 heterodimer transcriptional activity. Loop-region swapping between Hes1 and Hes6 partially exchanges their specific functions, indicating the loop region is functionally important.","method":"DNA binding assays; transcriptional reporter assays; retroviral misexpression in developing retina; domain-swap mutagenesis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro transcriptional assays plus mutagenesis plus in vivo retroviral misexpression, single lab with multiple orthogonal methods","pmids":["10851137"],"is_preprint":false},{"year":2000,"finding":"Hes1 functions as a bHLH transcriptional repressor that antagonizes positive bHLH factors (e.g., Mash1); misexpression of Hes1 inhibits differentiation and maintains precursor/proliferative state, while loss of Hes1 leads to upregulation of positive bHLH genes and premature differentiation across multiple tissues (brain, eye, pancreas, thymus).","method":"Hes1 knockout mouse model; Hes1 misexpression experiments; expression analysis of downstream bHLH targets","journal":"Molecules and cells","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function and gain-of-function across multiple tissue types with defined molecular targets","pmids":["10774739"],"is_preprint":false},{"year":2003,"finding":"Mathematical modeling demonstrates that the observed ~2-hour oscillatory expression of Hes1 mRNA and protein is driven by transcriptional time delays inherent in the negative autoregulatory feedback loop of Hes1; oscillation period is determined by the delay and the protein/mRNA half-lives.","method":"Mathematical modeling of delay differential equations constrained by experimental mRNA and protein half-life data","journal":"Current biology : CB","confidence":"Medium","confidence_rationale":"Tier 4 / Moderate — computational modeling informed by experimental data, no direct experimental manipulation; moderate because it is consistent with multiple subsequent experimental studies","pmids":["12932324"],"is_preprint":false},{"year":2004,"finding":"Hes-1 directly represses E2F-1 transcription through a CACGAG site in the E2F-1 promoter, inhibiting G1/S-phase transition and estrogen/heregulin-beta1-stimulated proliferation in breast cancer cells.","method":"Tetracycline-regulated HES-1 expression; dominant-negative HES-1; luciferase reporter with E2F-1 promoter and CACGAG site mutation; cell cycle analysis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — promoter-reporter with site-directed mutation plus dominant-negative validation plus cell cycle readout, single lab multiple orthogonal methods","pmids":["15467735"],"is_preprint":false},{"year":2004,"finding":"HES-1 is a novel transcriptional target of the aryl hydrocarbon receptor (AhR); AhR and HES-1 protein compete for binding to a composite HES/XRE element at -48/-42 in the HES-1 promoter, establishing a negative autoregulatory loop where HES-1 represses its own AhR-induced transcription.","method":"Actinomycin D transcription inhibition; luciferase reporter with HES-1 promoter; identification and mutation of XRE/HES composite element; protein competition assays","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays with functional element identification, single lab, multiple methods","pmids":["14722248"],"is_preprint":false},{"year":2004,"finding":"Notch/Hes-1 signaling blocks adipogenesis by suppressing C/EBPalpha and PPARgamma2 induction; constitutive Hes-1 expression mimics Jagged1-induced differentiation block, which can be rescued by ectopic C/EBPalpha or PPARgamma2. Additionally, Hes-1 down-regulates DLK/Pref-1 transcription, revealing a dual role in adipocyte development.","method":"Notch ligand (Jagged1) exposure of 3T3-L1 cells; retroviral Hes-1 expression; siRNA knockdown of Hes-1; retroviral rescue with C/EBPalpha and PPARgamma2","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — gain-of-function, loss-of-function, and rescue experiments with defined molecular targets, single lab with multiple orthogonal approaches","pmids":["15060169"],"is_preprint":false},{"year":2005,"finding":"Hes1 directly promotes progenitor cell proliferation by transcriptionally repressing the cyclin-dependent kinase inhibitor p27Kip1 through binding to class C sites in the p27Kip1 promoter; Hes1-deficient mouse tissues show elevated p27Kip1 transcripts.","method":"Tetracycline-inducible Hes1 expression; p27Kip1 promoter-reporter assays; chromatin immunoprecipitation; retinoic acid-induced Hes1 repression model; Hes1-null mouse tissue analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP demonstrating direct promoter binding, promoter reporter, inducible expression system, and confirmation in knockout mouse tissues","pmids":["15870295"],"is_preprint":false},{"year":2006,"finding":"Persistent and high-level Hes1 expression constitutively represses proneural bHLH gene (Mash1) expression in boundary cells of the developing CNS, forming neuron-free organizing centers; loss of Hes1/Hes3/Hes5 causes ectopic proneural gene expression and neurogenesis at boundaries.","method":"Hes1/Hes3/Hes5 compound knockout mice; retroviral persistent Hes1 expression in neural progenitors; in situ hybridization for Hes1 and Mash1","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — compound knockout with gain-of-function rescue, defined molecular target (Mash1 repression), multiple approaches","pmids":["16728479"],"is_preprint":false},{"year":2006,"finding":"HES1 inhibits hematopoietic progenitor cell cycling in a manner requiring its DNA-binding domain; HES1 overexpression upregulates p21(Cip1/Waf1) and inhibits cell expansion without inducing apoptosis or altering differentiation, while preserving long-term HSC reconstituting activity.","method":"Lentiviral overexpression of wild-type HES1 vs. DNA-binding domain deletion mutant (BHES1) in human CD34+ and mouse HSCs; in vitro cycling assays; in vivo repopulation assays","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — domain-deletion mutagenesis with in vitro and in vivo functional readouts, single lab, multiple orthogonal approaches","pmids":["16513761"],"is_preprint":false},{"year":2006,"finding":"Hes1 directly represses p57 transcription in pancreatic progenitors to maintain their cell cycle progression; Hes1 inactivation upregulates p57, causing cell cycle arrest and precocious differentiation. p57/Hes1 double-null embryos show expanded progenitor populations, confirming that p57 is a direct Hes1 target mediating progenitor self-renewal.","method":"Hes1 knockout mice; p57/Hes1 double knockout mice; expression analysis; genetic epistasis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis via double knockout with defined phenotypic rescue, replicated across genotypes","pmids":["16899237"],"is_preprint":false},{"year":2006,"finding":"Hes-1 expression is elevated in confluent endothelial cells through a Notch-independent mechanism involving c-Jun N-terminal kinase (JNK) signaling, demonstrating that HES-1 can be regulated by a non-Notch pathway.","method":"Comparison of Notch activation levels vs. Hes-1 protein in proliferating vs. confluent endothelial cells; pharmacological JNK inhibition; Western blot","journal":"Laboratory investigation","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — pharmacological inhibition with protein-level readout, single lab, limited mechanistic depth","pmids":["16732296"],"is_preprint":false},{"year":2007,"finding":"Stat3 oscillations, induced by serum, drive oscillatory Hes1 expression by regulating Hes1 protein half-life; coupled Stat-Hes1 oscillations are required for efficient G1 cell cycle progression and cell proliferation.","method":"Serum stimulation assays; identification of Stat3/Smad1 oscillations with their inhibitors Socs3/Smad6; Hes1 protein half-life measurements; loss of Hes1 oscillation with G1 phase analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple signaling components identified with functional cell cycle readout, single lab","pmids":["17592117"],"is_preprint":false},{"year":2007,"finding":"Id proteins directly interact with Hes1 protein and release its negative autoregulatory feedback (self-repression) without interfering with Hes1 repression of other target genes, thereby sustaining Hes1 expression levels in early neural tube and maintaining neural stem cell pools.","method":"Co-immunoprecipitation of Id2 with Hes1; Id2 overexpression in chick hindbrain; Id1/Id3 double knockout mice; Id1-3 RNAi in chick embryos; Hes1 expression analysis","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct protein interaction (Co-IP), loss-of-function (double KO and RNAi), and gain-of-function with mechanistic dissection, replicated across species","pmids":["17681138"],"is_preprint":false},{"year":2008,"finding":"HES1 directly represses 5-HT1A receptor transcription through a HES consensus site in the promoter; HES1 represses at both C(-1019) and G(-1019) alleles (unlike HES5 which is allele-selective). Loss of HES1 in knockout mice elevates 5-HT1A receptor expression in E12.5 hindbrain and midbrain, confirming HES1 is required for correct developmental 5-HT1A expression.","method":"HES1 promoter-reporter assays with consensus site mutation; HES1 overexpression and HES6 co-expression experiments; HES1-/- mouse 5-HT1A expression analysis","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — reporter assay with site mutation, confirmed in knockout mice, single lab multiple methods","pmids":["18499474"],"is_preprint":false},{"year":2011,"finding":"HES1 directly interacts with PARP1 in B-cell ALL; HES1-PARP1 interaction inhibits HES1 transcriptional function and activates PARP1, leading to PARP1 auto-ADP-ribosylation, NAD+ consumption, ATP depletion, and apoptosis-inducing factor nuclear translocation, causing apoptosis specifically in B-ALL but not T-ALL.","method":"Co-immunoprecipitation of HES1 and PARP1; PARP1 activation assays; NAD+/ATP measurements; AIF nuclear translocation assay; cell viability in B-ALL vs. T-ALL","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with functional biochemical readouts (PARP1 activation, NAD+, ATP, AIF translocation) and cell-type specificity, single lab multiple orthogonal methods","pmids":["21224467"],"is_preprint":false},{"year":2012,"finding":"GATA-1, facilitated by Ikaros, directly represses Hes1 gene expression in erythroid cells by recruiting FOG-1, NuRD/MI-2 ATPase, GFI1B, and the Polycomb repressive complex 2 (PRC2/EZH2) to the Hes1 locus; EZH2-mediated H3K27 methylation is required for transient Hes1 repression during erythroid differentiation.","method":"RNAi depletion of HES1 in mouse erythroleukemia cells; Ikaros-deficient mouse erythroid cells; ChIP for GATA-1, FOG-1, MI-2, GFI1B, EZH2 at Hes1 locus; EZH2 requirement assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP mapping of multiple chromatin regulators at Hes1 locus, loss-of-function with defined epigenetic mechanism, multiple orthogonal methods","pmids":["22778136"],"is_preprint":false},{"year":2013,"finding":"Hes1 directly binds to the promoter region of the FLT3 gene and represses its transcription; Hes1 deletion in MLL-AF9 leukemia cells upregulates FLT3, enhances FLT3L-stimulated ERK phosphorylation and proliferation, and FLT3 inhibition reverses Hes1-null AML cell proliferation.","method":"ChIP of Hes1 at FLT3 promoter; FLT3 promoter-reporter assays; Hes1 knockout in MLL-AF9 AML model; ERK phosphorylation assays; FLT3 inhibitor treatment","journal":"Leukemia","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP with promoter reporter, functional knockout with defined downstream signaling readout, single lab multiple methods","pmids":["25234168"],"is_preprint":false},{"year":2015,"finding":"HES1 directly represses BBC3 (encoding the pro-apoptotic PUMA) in T-ALL cells, thereby promoting tumor cell survival downstream of NOTCH1 signaling.","method":"HES1 knockdown in T-ALL; BBC3/PUMA expression analysis; functional apoptosis assays; ChIP at BBC3 locus","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus knockdown with apoptosis readout, single lab","pmids":["25784680"],"is_preprint":false},{"year":2015,"finding":"Ubiquitin-specific proteases Usp27x, Usp22, and Usp51 deubiquitinate and stabilize Hes1 protein; Usp22 knockdown shortens Hes1 half-life, delays Hes1 oscillations, and enhances neuronal differentiation in developing mouse brain, while Usp27x misexpression reduces neuronal differentiation.","method":"Hes1-specific antibody pulldown from mouse ES cells for deubiquitinase purification; deubiquitination assays; Usp22 knockdown (protein half-life, oscillation period measurement); Usp27x misexpression in developing brain","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — biochemical deubiquitination assay, protein half-life measurement, in vivo functional validation, single lab multiple orthogonal methods","pmids":["25846153"],"is_preprint":false},{"year":2016,"finding":"Hes1 suppresses inflammatory gene expression (specifically Cxcl1) by inhibiting recruitment of the positive transcription-elongation complex P-TEFb to the Cxcl1 locus, thereby preventing RNA Pol II Ser2 phosphorylation and productive elongation — a post-initiation mechanism distinct from typical pre-initiation transcriptional repression.","method":"Hes1 knockout macrophages; in vivo neutrophil recruitment assays; ChIP for P-TEFb and RNA Pol II Ser2 phosphorylation at Cxcl1; inflammatory arthritis model","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP mechanistic evidence for novel elongation-based repression plus in vivo loss-of-function with defined pathway readout, single rigorous study","pmids":["27322654"],"is_preprint":false},{"year":2016,"finding":"Hes1 attenuates type I IFN production not by directly repressing IFN genes, but by transcriptionally activating VEGF-C expression (a rare case of Hes1 acting as a transcriptional activator); VEGF-C induction suppresses the TLR upstream adaptor WDFY1, thereby dampening TLR signaling and IFN production.","method":"Hes1-deficient mice; genome-wide Hes1 ChIP-seq; VEGF-C and WDFY1 expression assays; ENCEPHALOMYOCARDITIS virus infection model; lupus nephritis model","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq with functional in vivo loss-of-function validation across multiple disease models, single lab with multiple orthogonal approaches","pmids":["31015298"],"is_preprint":false},{"year":2016,"finding":"CREB and Sirt-1 cooperatively regulate Hes1 promoter activity in neural stem cells in response to glucose availability: excess glucose promotes Sirt-1-dependent repression of the Hes1 promoter, while low glucose favors CREB replacement of Sirt-1 at Hes1 chromatin, enhancing Hes1 expression and proliferation.","method":"CREB-deficient NSCs; glucose manipulation; ChIP for CREB and Sirt-1 at Hes1 promoter; Hes1 promoter-reporter assays; NSC proliferation assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating competitive occupancy plus reporter assay plus functional NSC readout, single lab multiple methods","pmids":["26804914"],"is_preprint":false},{"year":2018,"finding":"Hes1 directly binds the GADD34 promoter and represses GADD34 expression during ER stress, protecting cells from apoptosis; HES1 depletion increases GADD34 expression and cell death during ER stress in a GADD34-dependent manner.","method":"HES1 depletion (siRNA/shRNA) in mouse and human cells; ChIP of HES1 at GADD34 promoter; GADD34 expression measurement; cell death assays with GADD34 dependency","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP of direct promoter binding, loss-of-function with epistatic GADD34 dependency, validated in multiple cell types","pmids":["29491143"],"is_preprint":false},{"year":2019,"finding":"In quiescent adult neural stem cells, Hes1 oscillates at higher levels than in active NSCs, keeping Ascl1 continuously suppressed; inactivation of Hes1 and related genes upregulates Ascl1 and increases neurogenesis causing NSC depletion, while sustained Hes1 overexpression represses Ascl1 and maintains quiescence.","method":"Hes1 conditional knockout mice (with Hes3/Hes5 compound deletion); live imaging of Hes1-Venus and Ascl1-Venus reporters in adult brain NSCs; sustained Hes1 overexpression; Ascl1 oscillation induction","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — live reporter imaging of oscillation dynamics, compound knockout, gain-of-function, multiple orthogonal approaches","pmids":["30862661"],"is_preprint":false},{"year":2019,"finding":"Hes1 oscillates in activated muscle stem cells and drives oscillatory MyoD expression; ablation of the Hes1 oscillator disrupts MyoD oscillations, leads to sustained MyoD expression and premature differentiation, impairing muscle stem cell maintenance and muscle growth/repair.","method":"Live imaging of Hes1 and MyoD reporters in dispersed cells, single muscle fiber cultures, and muscle biopsies; conditional Hes1 ablation; muscle regeneration assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — live imaging of oscillations with conditional knockout showing mechanistic link to MyoD dynamics and functional muscle phenotype","pmids":["30862660"],"is_preprint":false},{"year":2019,"finding":"Mutant KRAS-induced sustained Hes1 expression (via MAPK/ERK signaling) is required for acinar-to-ductal metaplasia (ADM) to progress to pancreatic intraepithelial neoplasia (PanIN); Hes1 ablation in KrasG12D mice forces ADM to re-differentiate back to acinar cells and prevents PDAC formation.","method":"Elastase1-CreERT2;KrasG12D mouse model with Hes1 genetic ablation; KrasG12D;Trp53R172H;Hes1-null PDAC model; gene expression analysis; lineage tracing","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional genetic ablation in multiple in vivo cancer models with lineage tracing and molecular characterization","pmids":["30705405"],"is_preprint":false},{"year":2019,"finding":"Epithelial Hes1 deletion modulates ciliogenesis and Smoothened ciliary accumulation in response to Shh; Hes1 potentiates hedgehog signaling in hair follicle stem cells to enable anagen initiation and HFSC self-renewal during repetitive depilation.","method":"Epithelial Hes1 conditional knockout mice; microarray gene profiling of HFSCs; primary keratinocyte ciliogenesis assays; Smoothened agonist rescue experiments","journal":"Stem cells (Dayton, Ohio)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with molecular rescue and in vitro ciliogenesis assay, single lab","pmids":["31721388"],"is_preprint":false},{"year":2020,"finding":"Hes1 deficiency in hematopoietic cells leads to HSC exhaustion under replicative stress by upregulating PPARgamma signaling and augmenting fatty acid oxidation (FAO); PPARgamma targeting or FAO inhibition rescues repopulating defects of Hes1-null HSCs by restoring quiescence.","method":"Hes1-flox/Vav1-Cre conditional knockout mice; bone marrow transplantation/stress hematopoiesis assays; transcriptome analysis; FAO measurement; pharmacological PPARgamma and FAO inhibition","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional knockout with pharmacological rescue identifying specific metabolic pathway, multiple orthogonal methods","pmids":["32129527"],"is_preprint":false},{"year":2020,"finding":"Robust Hes1 oscillations (high amplitude) are required for normal NPC proliferation and correct timing of neurogenesis; knock-in mice with dampened Hes1 oscillations (type-1 mutation) display smaller brains, decreased NPC proliferation, increased cell death, and upregulated proneural genes, while elongated-period (type-2) mutants are normal.","method":"Hes1 knock-in mice with shortened (type-1) and elongated (type-2) oscillation periods; brain morphometry; EdU proliferation assays; TUNEL apoptosis assays; proneural gene expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent knock-in alleles with opposing oscillation alterations allowing internal control, multiple phenotypic readouts","pmids":["32094111"],"is_preprint":false},{"year":2021,"finding":"RASSF1A acts as a scaffold for the SUMO-targeted E3 ubiquitin ligase SNURF/RNF4 to target HES1 for proteasomal degradation; RASSF1A loss stabilizes HES1 protein, promoting tumor dedifferentiation, independently of RASSF1A's role in the Hippo pathway.","method":"Co-immunoprecipitation of RASSF1A with HES1 and SNURF/RNF4; ubiquitination assays; proteasome inhibition; RASSF1A depletion with HES1 protein stability measurement; GSI sensitivity assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying scaffold interaction, biochemical ubiquitination assays, functional consequences demonstrated, single lab multiple methods","pmids":["34897944"],"is_preprint":false},{"year":2021,"finding":"HES1 oscillatory expression is specifically required for neural stem cells to exit quiescence; persistent (non-oscillatory) HES1 expression at physiological levels does not affect entry into quiescence or proliferation but specifically impedes quiescence exit.","method":"BMP4-induced quiescence in embryonic NSCs; persistent HES1 expression under moderate-strength promoter to override oscillations while maintaining total level; cell cycle and quiescence exit assays","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — specific manipulation of HES1 dynamics (oscillatory vs. persistent) at matched levels, single lab, functional quiescence assays","pmids":["34703994"],"is_preprint":false},{"year":2022,"finding":"In the medial prefrontal cortex, Hes1 directly binds to the GABAB1 receptor promoter and represses its transcription; Notch1-Hes1 signaling negatively regulates GABAB1 receptor expression and thereby modulates neuronal activity in methamphetamine-induced psychosis.","method":"ChIP of Hes1 at GABAB1 receptor promoter; Notch1 genetic and pharmacological manipulation; GABAB1 receptor expression and behavioral assays","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP of direct promoter binding with in vivo functional behavioral readout, single lab","pmids":["35732696"],"is_preprint":false},{"year":2022,"finding":"HES1 transcriptionally activates immunoglobulin-binding protein 1 (IGBP1) expression, which in turn promotes protein phosphatase 6 (PP6) expression and inhibits its ubiquitination; this HES1-IGBP1-PP6 axis is dysfunctional in psoriasis, and L-menthol upregulates HES1 by preventing its proteasomal degradation.","method":"Target identification screen with L-menthol; ChIP of HES1 at IGBP1 promoter; HES1 knockdown/overexpression; PP6 ubiquitination assays; HES1 protein stability assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP of direct transcriptional activation with downstream functional validation, single lab","pmids":["36535970"],"is_preprint":false},{"year":2023,"finding":"Oscillatory Hes1 expression directly represses p21 (Cdkn1a) to promote NSC proliferation; however, sustained Hes1 overexpression paradoxically upregulates p21 by repressing Dusp7 (a phosphatase for p-Erk) and increasing p-Erk levels, which indirectly elevates p21. Thus, Hes1 differentially controls cell proliferation depending on its expression dynamics.","method":"Oscillatory vs. sustained Hes1 expression in mouse NSCs; p21 expression measurement; Dusp7 expression analysis; p-Erk level measurement; proliferation assays","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional dissection of expression dynamics with molecular intermediates (Dusp7, p-Erk), single lab, multiple signaling readouts","pmids":["37200191"],"is_preprint":false},{"year":1994,"finding":"The human HES1 gene (HRY) encodes a bHLH protein with only four amino acid differences from the rat homolog; the coding region is contained within four exons; the locus was mapped by FISH to chromosome 3q28-q29.","method":"Genomic cloning; sequence analysis; fluorescence in situ hybridization (FISH)","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct chromosomal localization by FISH and gene structure by sequencing, single study","pmids":["8020957"],"is_preprint":false},{"year":1999,"finding":"Forced HES-1 expression in hippocampal neurons inhibits intrinsic and NGF-induced neurite outgrowth and blocks MASH-1-activated differentiation; even a non-DNA-binding mutant of HES-1 retains the ability to repress MASH-1-dependent transcription, indicating a DNA-binding-independent repression mechanism.","method":"Retroviral HES-1 and MASH-1 expression in TrkA-transfected hippocampal neurons; NGF-induced differentiation assay; non-DNA-binding HES-1 mutant co-expression; reporter assays","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with domain mutant revealing DNA-binding-independent repression, single lab multiple approaches","pmids":["10336252"],"is_preprint":false},{"year":2020,"finding":"MYEOV interacts directly with SOX9 in the nucleus and enhances SOX9 DNA-binding ability to the HES1 enhancer, promoting HES1 transcription; HES1 knockdown partially abolishes MYEOV oncogenic effects in pancreatic cancer.","method":"Co-immunoprecipitation of MYEOV and SOX9; ChIP of SOX9 at HES1 enhancer; HES1 reporter assays; HES1 knockdown rescue experiments","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ChIP plus functional rescue, single lab","pmids":["32879444"],"is_preprint":false},{"year":2023,"finding":"HES1 directly binds the IGF2BP2 promoter and promotes IGF2BP2 expression; IGF2BP2 then recognizes and binds the m6A site in GLUT1 mRNA, enhancing its stability and promoting aerobic glycolysis in colorectal cancer cells.","method":"ChIP-PCR of HES1 at IGF2BP2 promoter; dual-luciferase reporter assay; HES1/IGF2BP2 knockdown; GLUT1 mRNA stability measurement; m6A site analysis","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with reporter assay and downstream RNA stability mechanism, single lab","pmids":["37957183"],"is_preprint":false}],"current_model":"HES1 is a bHLH transcriptional repressor that functions as the primary downstream effector of Notch signaling — activated through the Delta/Jagged → Notch → RBP-J axis — and suppresses proneural/pro-differentiation bHLH factors (Mash1/Ascl1, Math5) and cell-cycle inhibitors (p27Kip1, p57, p21) by directly binding their promoters; its expression oscillates with ~2–3 hour periodicity driven by transcriptional time-delay negative autoregulation, and these oscillations are functionally distinct from sustained high-level expression — oscillatory Hes1 promotes stem cell proliferation while sustained Hes1 enforces quiescence or boundary identity; Hes1 protein stability is regulated by ubiquitin/proteasome degradation (counteracted by deubiquitinases Usp27x/Usp22/Usp51 and promoted by RASSF1A-scaffolded SNURF/RNF4); Hes1 also suppresses inflammatory responses by blocking P-TEFb-dependent transcription elongation at Cxcl1 and attenuates TLR/type I IFN signaling by transcriptionally activating VEGF-C to suppress WDFY1; non-Notch inputs including JNK, MAPK/ERK (via Kras), Stat3, CREB/Sirt-1, and AhR can regulate Hes1 expression independently of the canonical pathway."},"narrative":{"mechanistic_narrative":"HES1 is a basic helix-loop-helix transcriptional repressor that operates as the principal downstream effector of Notch signaling, governing the balance between progenitor maintenance and differentiation across neural, pancreatic, hematopoietic, and muscle lineages [PMID:10205173, PMID:9819428, PMID:10774739]. Delta-1 engagement of Notch-1 drives RBP-J (CSL)-dependent transcriptional induction of HES1, and HES1 together with HES5 is genetically required for Notch to block neuronal differentiation [PMID:10205173, PMID:9819428]. The canonical output of HES1 is repression of proneural/pro-differentiation bHLH factors such as Mash1/Ascl1, which keeps precursor cells undifferentiated and, when lost, causes premature differentiation and progenitor depletion in multiple tissues [PMID:10615124, PMID:10774739, PMID:16728479, PMID:30862661]. HES1 sustains progenitor proliferation by directly repressing cell-cycle inhibitors — p27Kip1, p57, p21/Cip1, and E2F-1 — through binding to class C/CACGAG sites in their promoters [PMID:15467735, PMID:15870295, PMID:16513761, PMID:16899237]. A defining feature of HES1 is that its expression oscillates with ~2-hour periodicity generated by transcriptional time-delay negative autoregulation, and these oscillations are functionally distinct from sustained high-level expression: oscillatory HES1 keeps Ascl1 (and MyoD) suppressed to promote stem-cell proliferation and quiescence exit, whereas persistent high-level HES1 enforces sustained Ascl1 repression, quiescence, or boundary (neuron-free) identity [PMID:12932324, PMID:16728479, PMID:30862661, PMID:30862660, PMID:32094111, PMID:34703994]. HES1 protein levels are set by ubiquitin/proteasome turnover, antagonized by the deubiquitinases Usp27x/Usp22/Usp51 and promoted by RASSF1A-scaffolded SNURF/RNF4-mediated degradation [PMID:25846153, PMID:34897944]. Beyond progenitor control, HES1 restrains inflammatory and innate-immune responses, blocking P-TEFb-dependent transcription elongation at Cxcl1 and, atypically acting as an activator, inducing VEGF-C to suppress the TLR adaptor WDFY1 [PMID:27322654, PMID:31015298]. HES1 expression is additionally tuned by non-Notch inputs including JNK, oncogenic KRAS/MAPK-ERK, Stat3, CREB/Sirt-1, and the aryl hydrocarbon receptor [PMID:14722248, PMID:16732296, PMID:17592117, PMID:26804914, PMID:30705405].","teleology":[{"year":1994,"claim":"Establishing the human HES1 gene structure and chromosomal location provided the molecular foundation for studying it as a conserved bHLH factor.","evidence":"Genomic cloning, sequencing, and FISH mapping of human HRY/HES1","pmids":["8020957"],"confidence":"Medium","gaps":["Does not address function or regulation","No protein interaction or target data"]},{"year":1998,"claim":"Defining HES1 as a direct transcriptional target of the Delta/Notch/RBP-J axis answered how Notch signal is converted into a transcriptional output.","evidence":"Two-cell coculture with HES1 promoter-luciferase reporter, endogenous mRNA measurement, and dominant-negative Kuzbanian/RBP-J inhibition","pmids":["9819428"],"confidence":"High","gaps":["Does not show which downstream genes HES1 then regulates","Cell-type generality of RBP-J dependence not tested"]},{"year":1999,"claim":"Genetic epistasis placed HES1/HES5 downstream of Notch as obligatory effectors, showing Notch cannot block neuronal differentiation without them.","evidence":"Constitutively active Notch misexpression in Hes1/Hes5 single- and double-null neural precursors","pmids":["10205173"],"confidence":"High","gaps":["Direct DNA targets mediating the block not defined here","Redundancy with other HES/HEY factors not fully resolved"]},{"year":1999,"claim":"Demonstrating that a non-DNA-binding HES-1 mutant still represses MASH-1 revealed a DNA-binding-independent mode of repression alongside its canonical promoter binding.","evidence":"Retroviral HES-1/MASH-1 expression with non-DNA-binding mutant in hippocampal neurons and reporter assays","pmids":["10336252"],"confidence":"Medium","gaps":["Molecular basis of DNA-binding-independent repression unresolved","Relative contribution of each mode in vivo unknown"]},{"year":2000,"claim":"Loss- and gain-of-function across multiple tissues established HES1 as a general repressor of proneural/endocrine bHLH factors that keeps precursors undifferentiated.","evidence":"Hes1 knockout mice with histology/expression analysis in pancreas, gut, brain, eye, thymus and misexpression studies","pmids":["10615124","10774739"],"confidence":"High","gaps":["Direct vs indirect target regulation not fully separated","Mechanism of repression at each target undefined at this stage"]},{"year":2000,"claim":"Identifying Hes6 as a HES1 antagonist and mapping the loop region defined how HES1 repressive activity itself is modulated.","evidence":"DNA-binding/reporter assays, retinal retroviral misexpression, and loop-region domain swaps","pmids":["10851137"],"confidence":"High","gaps":["Structural basis of Hes6 inhibition not resolved","In vivo physiological relevance limited to retina"]},{"year":2004,"claim":"Defining HES1 control of E2F-1 and adipogenic regulators (C/EBPalpha, PPARgamma2, DLK/Pref-1) connected HES1 repression directly to cell-cycle entry and lineage commitment.","evidence":"Inducible/dominant-negative HES1, promoter-reporter with site mutation, and Jagged1/Hes1 gain- and loss-of-function with rescue in 3T3-L1 cells","pmids":["15467735","15060169"],"confidence":"High","gaps":["Direct promoter binding to adipogenic genes not all demonstrated","Tissue specificity of the E2F-1 axis untested"]},{"year":2004,"claim":"Discovery that AhR transcriptionally induces HES1, with HES1 repressing its own AhR-driven transcription, introduced a non-Notch input and an autoregulatory loop.","evidence":"Promoter-reporter assays with XRE/HES composite element identification and protein competition assays","pmids":["14722248"],"confidence":"Medium","gaps":["Physiological context of AhR-HES1 loop not established in vivo","Single-lab reporter-based evidence"]},{"year":2005,"claim":"ChIP-level evidence that HES1 directly represses p27Kip1 explained mechanistically how HES1 promotes progenitor proliferation.","evidence":"Inducible Hes1, p27Kip1 promoter-reporter, ChIP, and Hes1-null tissue analysis","pmids":["15870295"],"confidence":"High","gaps":["Whether p27 repression is sufficient for proliferation control not isolated","Interplay with other CDK inhibitor targets not addressed here"]},{"year":2006,"claim":"Extending direct repression to p57 (with double-knockout epistasis), p21, and demonstrating boundary-cell roles unified HES1 control of progenitor self-renewal and organizer identity.","evidence":"Hes1/p57 and Hes1/Hes3/Hes5 compound knockouts, DNA-binding-domain-dependent HSC assays, and persistent Hes1 misexpression","pmids":["16899237","16513761","16728479"],"confidence":"High","gaps":["Quantitative contribution of each CDK inhibitor target differs by tissue","How sustained vs dynamic expression dictates boundary vs progenitor fate not yet mechanistically defined"]},{"year":2006,"claim":"Identifying JNK-driven, Notch-independent HES1 induction in confluent endothelium broadened the regulatory inputs beyond the canonical pathway.","evidence":"Proliferating vs confluent endothelial comparison with pharmacological JNK inhibition and Western blot","pmids":["16732296"],"confidence":"Medium","gaps":["Direct JNK-to-HES1 transcriptional mechanism not mapped","Pharmacological inhibition only; limited mechanistic depth"]},{"year":2007,"claim":"Mathematical modeling plus identification of Id-protein and Stat3 inputs explained how the HES1 oscillator is generated and how its autoregulation and protein half-life are tuned.","evidence":"Delay differential equation modeling constrained by half-life data; Id2 Co-IP with loss/gain-of-function; serum-induced Stat3 oscillation and Hes1 half-life measurement","pmids":["12932324","17681138","17592117"],"confidence":"Medium","gaps":["Modeling lacks direct experimental perturbation of the delay","How Id and Stat3 inputs integrate quantitatively not resolved"]},{"year":2008,"claim":"Demonstration that HES1 directly represses 5-HT1A and (later) GABAB1 receptor genes extended its repressor role to neurotransmitter-receptor programming.","evidence":"Promoter-reporter with consensus-site mutation, HES1-null receptor expression analysis, and ChIP at GABAB1 promoter with behavioral readouts","pmids":["18499474","35732696"],"confidence":"Medium","gaps":["Behavioral consequences mechanistically indirect","Allele-selectivity and receptor specificity incompletely generalized"]},{"year":2012,"claim":"Mapping GATA-1/Ikaros recruitment of NuRD and PRC2/EZH2 to the Hes1 locus revealed how HES1 itself is epigenetically silenced during lineage commitment.","evidence":"ChIP of GATA-1, FOG-1, MI-2, GFI1B, and EZH2 at the Hes1 locus in erythroid cells with EZH2 requirement assays","pmids":["22778136"],"confidence":"High","gaps":["Whether this repressive module operates outside erythroid cells unknown","Dynamics relative to oscillation not addressed"]},{"year":2015,"claim":"Identifying deubiquitinase (Usp22/Usp27x/Usp51) control of HES1 stability connected protein turnover directly to oscillation period and differentiation timing.","evidence":"HES1 antibody pulldown for DUB purification, deubiquitination assays, Usp22 knockdown with half-life/oscillation measurement, and in vivo Usp27x misexpression","pmids":["25846153"],"confidence":"High","gaps":["E3 ligase(s) opposing these DUBs not identified here","Tissue-specific DUB usage not mapped"]},{"year":2015,"claim":"Identifying HES1 repression of BBC3/PUMA and interaction with PARP1 showed HES1 contributes to leukemic survival and revealed a cell-type-specific cytotoxic vulnerability.","evidence":"HES1 knockdown with ChIP at BBC3 and apoptosis assays in T-ALL; reciprocal HES1-PARP1 Co-IP with NAD+/ATP/AIF readouts in B-ALL","pmids":["25784680","21224467"],"confidence":"Medium","gaps":["Why PARP1 engagement is B-ALL-specific not fully explained","BBC3 finding from single lab with knockdown only"]},{"year":2016,"claim":"Discovery of elongation-based (P-TEFb) repression at Cxcl1 and activator function inducing VEGF-C/WDFY1 established HES1 roles in restraining inflammation and innate immunity by non-canonical mechanisms.","evidence":"Hes1-null macrophages with ChIP for P-TEFb/Pol II Ser2; genome-wide ChIP-seq with VEGF-C/WDFY1 assays in infection and lupus models","pmids":["27322654","31015298"],"confidence":"High","gaps":["How HES1 switches between repressor and activator modes unresolved","Direct vs indirect VEGF-C activation mechanism not fully dissected"]},{"year":2018,"claim":"Demonstrating direct HES1 repression of GADD34 linked HES1 to cytoprotection during ER stress.","evidence":"HES1 depletion with ChIP at GADD34 promoter and GADD34-dependent cell-death assays in mouse and human cells","pmids":["29491143"],"confidence":"High","gaps":["Upstream signal controlling HES1 during ER stress not defined","Relationship to oscillation dynamics unknown"]},{"year":2019,"claim":"Live-imaging of oscillation dynamics in neural and muscle stem cells established the functional distinction between oscillatory and sustained HES1 in driving proliferation versus quiescence/differentiation.","evidence":"Hes1/Ascl1 and Hes1/MyoD reporter live imaging with conditional knockout and sustained overexpression in adult NSCs and muscle stem cells","pmids":["30862661","30862660"],"confidence":"High","gaps":["Molecular machinery sensing oscillatory vs sustained dynamics unknown","How downstream effectors decode HES1 frequency unresolved"]},{"year":2019,"claim":"Showing KRAS/MAPK-ERK-driven sustained HES1 is required for ADM-to-PanIN progression, and that HES1 potentiates hedgehog signaling, expanded HES1 roles into oncogenic and ciliary contexts.","evidence":"Conditional Hes1 ablation in KrasG12D pancreatic models with lineage tracing; epithelial Hes1 knockout with ciliogenesis and Smoothened rescue in hair follicle stem cells","pmids":["30705405","31721388"],"confidence":"High","gaps":["Direct HES1 targets driving PanIN progression not specified","Mechanism of HES1 control over ciliary Smoothened accumulation unclear"]},{"year":2020,"claim":"Defining HES1 control of HSC metabolism (PPARgamma/FAO) and the quantitative requirement for robust oscillation amplitude refined how HES1 enforces quiescence and proper neurogenic timing.","evidence":"Hes1 conditional knockout HSC transplantation with FAO/PPARgamma pharmacological rescue; type-1/type-2 oscillation knock-in alleles with brain morphometry and proliferation/apoptosis assays","pmids":["32129527","32094111"],"confidence":"High","gaps":["Direct HES1 target in the PPARgamma/FAO axis not identified","How amplitude is read out by progenitors unknown"]},{"year":2021,"claim":"Identifying RASSF1A/SNURF-RNF4-mediated degradation and showing oscillation is specifically required for quiescence exit completed a stability-and-dynamics regulatory picture with tumor and stem-cell consequences.","evidence":"RASSF1A-HES1-SNURF/RNF4 Co-IP and ubiquitination assays with stability measurement; matched-level persistent vs oscillatory HES1 in BMP4-induced quiescent NSCs","pmids":["34897944","34703994"],"confidence":"Medium","gaps":["How SUMO-targeted degradation integrates with DUB activity unresolved","Quiescence-exit finding is single-lab"]},{"year":2022,"claim":"Identifying HES1 activator targets IGBP1/PP6 (in psoriasis) and MYEOV/SOX9-driven HES1 induction added activator functions and upstream transcriptional regulators in disease contexts.","evidence":"ChIP at IGBP1 promoter with PP6 ubiquitination and HES1 stability assays; MYEOV-SOX9 Co-IP and ChIP at HES1 enhancer with knockdown rescue","pmids":["36535970","32879444"],"confidence":"Medium","gaps":["Determinants of HES1 activator vs repressor behavior unresolved","Single-lab evidence for each axis"]},{"year":2023,"claim":"Dissecting dynamics-dependent p21 control (Dusp7/p-Erk) and metabolic reprogramming via IGF2BP2/GLUT1 showed HES1 output depends on its expression mode and reaches into glycolytic metabolism.","evidence":"Oscillatory vs sustained Hes1 in NSCs with Dusp7/p-Erk/p21 readouts; HES1 ChIP at IGF2BP2 promoter with GLUT1 mRNA stability and glycolysis assays","pmids":["37200191","37957183"],"confidence":"Medium","gaps":["Generality of the dynamics-dependent paradoxical p21 effect untested","Metabolic axis demonstrated mainly in colorectal cancer cells"]},{"year":null,"claim":"It remains unresolved how the molecular machinery distinguishes oscillatory from sustained HES1 and how HES1 switches between transcriptional repressor and activator modes at different loci.","evidence":"No discovery in the timeline defines the decoder of HES1 dynamics or the determinant of its repressor/activator choice","pmids":[],"confidence":"Low","gaps":["No mechanism linking oscillation frequency/amplitude to target decoding","No structural or cofactor basis explaining activator vs repressor switching","Opposing E3 ligase/DUB balance across tissues incompletely mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,4,6,9,12,22,23]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[6,9,11,16,19,25]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[15,17,39]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[9,12,22,23]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,4,10,26]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[6,9,11,12,36]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[22,23]}],"complexes":[],"partners":["RBPJ","HES6","ID2","PARP1","RASSF1A","RNF4","USP22"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q14469","full_name":"Transcription factor HES-1","aliases":["Class B basic helix-loop-helix protein 39","bHLHb39","Hairy and enhancer of split 1","Hairy homolog","Hairy-like protein","hHL"],"length_aa":280,"mass_kda":29.5,"function":"Transcriptional repressor of genes that require a bHLH protein for their transcription. May act as a negative regulator of myogenesis by inhibiting the functions of MYOD1 and ASH1. Binds DNA on N-box motifs: 5'-CACNAG-3' with high affinity and on E-box motifs: 5'-CANNTG-3' with low affinity (By similarity). May play a role in a functional FA core complex response to DNA cross-link damage, being required for the stability and nuclear localization of FA core complex proteins, as well as for FANCD2 monoubiquitination in response to DNA damage","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q14469/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HES1","classification":"Not Classified","n_dependent_lines":22,"n_total_lines":1208,"dependency_fraction":0.018211920529801324},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HES1","total_profiled":1310},"omim":[{"mim_id":"621173","title":"G PROTEIN-COUPLED RECEPTOR 146; GPR146","url":"https://www.omim.org/entry/621173"},{"mim_id":"621120","title":"DELTA-LIKE NONCANONICAL NOTCH LIGAND 2; DLK2","url":"https://www.omim.org/entry/621120"},{"mim_id":"618111","title":"ZINC FINGER PROTEIN 64; ZFP64","url":"https://www.omim.org/entry/618111"},{"mim_id":"618081","title":"IMMUNOGLOBULIN-LIKE DOMAIN-CONTAINING RECEPTOR 2; ILDR2","url":"https://www.omim.org/entry/618081"},{"mim_id":"617546","title":"HELT bHLH TRANSCRIPTION FACTOR; HELT","url":"https://www.omim.org/entry/617546"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HES1"},"hgnc":{"alias_symbol":["FLJ20408","HES-1","bHLHb39"],"prev_symbol":["HRY"]},"alphafold":{"accession":"Q14469","domains":[{"cath_id":"4.10.280.10","chopping":"37-102","consensus_level":"medium","plddt":87.09,"start":37,"end":102},{"cath_id":"1.10.287","chopping":"103-154","consensus_level":"medium","plddt":89.8852,"start":103,"end":154}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14469","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q14469-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q14469-F1-predicted_aligned_error_v6.png","plddt_mean":68.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HES1","jax_strain_url":"https://www.jax.org/strain/search?query=HES1"},"sequence":{"accession":"Q14469","fasta_url":"https://rest.uniprot.org/uniprotkb/Q14469.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q14469/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14469"}},"corpus_meta":[{"pmid":"10615124","id":"PMC_10615124","title":"Control of endodermal endocrine development by Hes-1.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10615124","citation_count":930,"is_preprint":false},{"pmid":"10205173","id":"PMC_10205173","title":"Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10205173","citation_count":699,"is_preprint":false},{"pmid":"12932324","id":"PMC_12932324","title":"Oscillatory expression of Hes1, p53, and NF-kappaB driven by transcriptional time delays.","date":"2003","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/12932324","citation_count":403,"is_preprint":false},{"pmid":"9819428","id":"PMC_9819428","title":"Delta-1 activation of notch-1 signaling results in HES-1 transactivation.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9819428","citation_count":283,"is_preprint":false},{"pmid":"10851137","id":"PMC_10851137","title":"The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10851137","citation_count":216,"is_preprint":false},{"pmid":"15870295","id":"PMC_15870295","title":"Hes1 directly controls cell proliferation through the transcriptional repression of p27Kip1.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15870295","citation_count":183,"is_preprint":false},{"pmid":"16728479","id":"PMC_16728479","title":"Persistent and high levels of Hes1 expression regulate boundary formation in the developing central nervous system.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16728479","citation_count":177,"is_preprint":false},{"pmid":"10605019","id":"PMC_10605019","title":"A role for pref-1 and HES-1 in thymocyte development.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10605019","citation_count":164,"is_preprint":false},{"pmid":"17681138","id":"PMC_17681138","title":"Id sustains Hes1 expression to inhibit precocious neurogenesis by releasing negative autoregulation of Hes1.","date":"2007","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/17681138","citation_count":158,"is_preprint":false},{"pmid":"25781910","id":"PMC_25781910","title":"Hes1: a key role in stemness, metastasis and multidrug resistance.","date":"2015","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25781910","citation_count":151,"is_preprint":false},{"pmid":"26076648","id":"PMC_26076648","title":"Wnt and Notch signaling pathway involved in wound healing by targeting c-Myc and Hes1 separately.","date":"2015","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/26076648","citation_count":135,"is_preprint":false},{"pmid":"17611704","id":"PMC_17611704","title":"Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.","date":"2007","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17611704","citation_count":134,"is_preprint":false},{"pmid":"30862661","id":"PMC_30862661","title":"High Hes1 expression and resultant Ascl1 suppression regulate quiescent vs. active neural stem cells in the adult mouse brain.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/30862661","citation_count":132,"is_preprint":false},{"pmid":"16899237","id":"PMC_16899237","title":"p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16899237","citation_count":130,"is_preprint":false},{"pmid":"15060169","id":"PMC_15060169","title":"Dual roles for the Notch target gene Hes-1 in the differentiation of 3T3-L1 preadipocytes.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15060169","citation_count":129,"is_preprint":false},{"pmid":"10774739","id":"PMC_10774739","title":"The bHLH gene Hes1 regulates differentiation of multiple cell types.","date":"2000","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/10774739","citation_count":128,"is_preprint":false},{"pmid":"17592117","id":"PMC_17592117","title":"Ultradian oscillations of Stat, Smad, and Hes1 expression in response to serum.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17592117","citation_count":105,"is_preprint":false},{"pmid":"16513761","id":"PMC_16513761","title":"HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding.","date":"2006","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/16513761","citation_count":98,"is_preprint":false},{"pmid":"16038893","id":"PMC_16038893","title":"Multiple requirements for Hes 1 during early eye formation.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16038893","citation_count":93,"is_preprint":false},{"pmid":"18418349","id":"PMC_18418349","title":"Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury.","date":"2008","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/18418349","citation_count":90,"is_preprint":false},{"pmid":"24492635","id":"PMC_24492635","title":"Hes1 is involved in the self-renewal and tumourigenicity of stem-like cancer cells in colon cancer.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/24492635","citation_count":87,"is_preprint":false},{"pmid":"16732296","id":"PMC_16732296","title":"Notch-independent regulation of Hes-1 expression by c-Jun N-terminal kinase signaling in human endothelial cells.","date":"2006","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16732296","citation_count":82,"is_preprint":false},{"pmid":"20022559","id":"PMC_20022559","title":"Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells.","date":"2009","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20022559","citation_count":78,"is_preprint":false},{"pmid":"27322654","id":"PMC_27322654","title":"The transcriptional repressor Hes1 attenuates inflammation by regulating transcription elongation.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27322654","citation_count":76,"is_preprint":false},{"pmid":"19541765","id":"PMC_19541765","title":"The notch target gene HES1 regulates cell cycle inhibitor expression in the developing pituitary.","date":"2009","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19541765","citation_count":73,"is_preprint":false},{"pmid":"20545770","id":"PMC_20545770","title":"Hes1 regulates embryonic stem cell differentiation by suppressing Notch signaling.","date":"2010","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/20545770","citation_count":73,"is_preprint":false},{"pmid":"15465493","id":"PMC_15465493","title":"Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis.","date":"2004","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15465493","citation_count":71,"is_preprint":false},{"pmid":"22871495","id":"PMC_22871495","title":"The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma.","date":"2012","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/22871495","citation_count":71,"is_preprint":false},{"pmid":"17367776","id":"PMC_17367776","title":"Hes1 is required for pituitary growth and melanotrope specification.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17367776","citation_count":70,"is_preprint":false},{"pmid":"27066918","id":"PMC_27066918","title":"HES1 in immunity and cancer.","date":"2016","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/27066918","citation_count":69,"is_preprint":false},{"pmid":"30862660","id":"PMC_30862660","title":"Oscillations of MyoD and Hes1 proteins regulate the maintenance of activated muscle stem cells.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/30862660","citation_count":66,"is_preprint":false},{"pmid":"26804914","id":"PMC_26804914","title":"A CREB-Sirt1-Hes1 Circuitry Mediates Neural Stem Cell Response to Glucose Availability.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26804914","citation_count":61,"is_preprint":false},{"pmid":"27233500","id":"PMC_27233500","title":"Hes1: the maestro in neurogenesis.","date":"2016","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/27233500","citation_count":58,"is_preprint":false},{"pmid":"32094111","id":"PMC_32094111","title":"Oscillatory expression of Hes1 regulates cell proliferation and neuronal differentiation in the embryonic brain.","date":"2020","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32094111","citation_count":57,"is_preprint":false},{"pmid":"10336252","id":"PMC_10336252","title":"Regulation of hippocampal neuronal differentiation by the basic helix-loop-helix transcription factors HES-1 and MASH-1.","date":"1999","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/10336252","citation_count":55,"is_preprint":false},{"pmid":"14722248","id":"PMC_14722248","title":"HES-1, a novel target gene for the aryl hydrocarbon receptor.","date":"2004","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/14722248","citation_count":54,"is_preprint":false},{"pmid":"25817041","id":"PMC_25817041","title":"Activation of OR1A1 suppresses PPAR-γ expression by inducing HES-1 in cultured hepatocytes.","date":"2015","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25817041","citation_count":54,"is_preprint":false},{"pmid":"22778136","id":"PMC_22778136","title":"GATA-1 utilizes Ikaros and polycomb repressive complex 2 to suppress Hes1 and to promote erythropoiesis.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22778136","citation_count":54,"is_preprint":false},{"pmid":"21224467","id":"PMC_21224467","title":"Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21224467","citation_count":54,"is_preprint":false},{"pmid":"15033430","id":"PMC_15033430","title":"Roles of the bHLH gene Hes1 in retinal morphogenesis.","date":"2004","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15033430","citation_count":53,"is_preprint":false},{"pmid":"25846153","id":"PMC_25846153","title":"Deubiquitinating enzymes regulate Hes1 stability and neuronal differentiation.","date":"2015","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/25846153","citation_count":52,"is_preprint":false},{"pmid":"31517391","id":"PMC_31517391","title":"DNA-methylation-mediated silencing of miR-7-5p promotes gastric cancer stem cell invasion via increasing Smo and Hes1.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31517391","citation_count":52,"is_preprint":false},{"pmid":"15467735","id":"PMC_15467735","title":"HES-1 inhibits 17beta-estradiol and heregulin-beta1-mediated upregulation of E2F-1.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15467735","citation_count":51,"is_preprint":false},{"pmid":"26431046","id":"PMC_26431046","title":"miR-381 Regulates Neural Stem Cell Proliferation and Differentiation via Regulating Hes1 Expression.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26431046","citation_count":51,"is_preprint":false},{"pmid":"21084301","id":"PMC_21084301","title":"HES1 (hairy and enhancer of split 1) is a determinant of bone mass.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21084301","citation_count":50,"is_preprint":false},{"pmid":"22411914","id":"PMC_22411914","title":"The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.","date":"2012","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22411914","citation_count":48,"is_preprint":false},{"pmid":"15013216","id":"PMC_15013216","title":"The Notch signaling cascade in neuroblastoma: role of the basic helix-loop-helix proteins HASH-1 and HES-1.","date":"2004","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/15013216","citation_count":46,"is_preprint":false},{"pmid":"26452029","id":"PMC_26452029","title":"Hes1 promotes cell proliferation and migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human colon cancer.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26452029","citation_count":46,"is_preprint":false},{"pmid":"26823491","id":"PMC_26823491","title":"Tigecycline Inhibits Glioma Growth by Regulating miRNA-199b-5p-HES1-AKT Pathway.","date":"2016","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/26823491","citation_count":42,"is_preprint":false},{"pmid":"31919081","id":"PMC_31919081","title":"HES1 and HES4 have non-redundant roles downstream of Notch during early human T-cell development.","date":"2021","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/31919081","citation_count":39,"is_preprint":false},{"pmid":"25784680","id":"PMC_25784680","title":"Therapeutic targeting of HES1 transcriptional programs in T-ALL.","date":"2015","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25784680","citation_count":39,"is_preprint":false},{"pmid":"32129527","id":"PMC_32129527","title":"Hes1 deficiency causes hematopoietic stem cell exhaustion.","date":"2020","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/32129527","citation_count":36,"is_preprint":false},{"pmid":"25234168","id":"PMC_25234168","title":"Hes1 suppresses acute myeloid leukemia development through FLT3 repression.","date":"2014","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/25234168","citation_count":36,"is_preprint":false},{"pmid":"31721388","id":"PMC_31721388","title":"Hes1 regulates anagen initiation and hair follicle regeneration through modulation of hedgehog signaling.","date":"2019","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/31721388","citation_count":36,"is_preprint":false},{"pmid":"29297498","id":"PMC_29297498","title":"Epithelial Hes1 maintains gut homeostasis by preventing microbial dysbiosis.","date":"2018","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29297498","citation_count":35,"is_preprint":false},{"pmid":"8020957","id":"PMC_8020957","title":"Genomic cloning and chromosomal localization of HRY, the human homolog to the Drosophila segmentation gene, hairy.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8020957","citation_count":32,"is_preprint":false},{"pmid":"32879444","id":"PMC_32879444","title":"MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/32879444","citation_count":32,"is_preprint":false},{"pmid":"37957183","id":"PMC_37957183","title":"HES1 promotes aerobic glycolysis and cancer progression of colorectal cancer via IGF2BP2-mediated GLUT1 m6A modification.","date":"2023","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/37957183","citation_count":32,"is_preprint":false},{"pmid":"37200191","id":"PMC_37200191","title":"Differential cell-cycle control by oscillatory versus sustained Hes1 expression via p21.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37200191","citation_count":31,"is_preprint":false},{"pmid":"30705405","id":"PMC_30705405","title":"Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30705405","citation_count":30,"is_preprint":false},{"pmid":"31949107","id":"PMC_31949107","title":"Simultaneous Requirements for Hes1 in Retinal Neurogenesis and Optic Cup-Stalk Boundary Maintenance.","date":"2020","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31949107","citation_count":30,"is_preprint":false},{"pmid":"23686434","id":"PMC_23686434","title":"The role of dimerisation and nuclear transport in the Hes1 gene regulatory network.","date":"2013","source":"Bulletin of mathematical biology","url":"https://pubmed.ncbi.nlm.nih.gov/23686434","citation_count":29,"is_preprint":false},{"pmid":"18499474","id":"PMC_18499474","title":"HES1 regulates 5-HT1A receptor gene transcription at a functional polymorphism: essential role in developmental expression.","date":"2008","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/18499474","citation_count":28,"is_preprint":false},{"pmid":"27639167","id":"PMC_27639167","title":"Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.","date":"2016","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27639167","citation_count":28,"is_preprint":false},{"pmid":"23509692","id":"PMC_23509692","title":"miR-1-mediated induction of cardiogenesis in mesenchymal stem cells via downregulation of Hes-1.","date":"2012","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/23509692","citation_count":27,"is_preprint":false},{"pmid":"39364745","id":"PMC_39364745","title":"Curcumin pretreatment attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis, autophagy and apoptosis via HES1.","date":"2024","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39364745","citation_count":26,"is_preprint":false},{"pmid":"19891787","id":"PMC_19891787","title":"Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferation.","date":"2009","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/19891787","citation_count":26,"is_preprint":false},{"pmid":"30261495","id":"PMC_30261495","title":"microRNA-203 Modulates Wound Healing and Scar Formation via Suppressing Hes1 Expression in Epidermal Stem Cells.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30261495","citation_count":26,"is_preprint":false},{"pmid":"36535970","id":"PMC_36535970","title":"Targeting the transcription factor HES1 by L-menthol restores protein phosphatase 6 in keratinocytes in models of psoriasis.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36535970","citation_count":26,"is_preprint":false},{"pmid":"25550047","id":"PMC_25550047","title":"Control of hair cell development by molecular pathways involving Atoh1, Hes1 and Hes5.","date":"2014","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/25550047","citation_count":25,"is_preprint":false},{"pmid":"33390847","id":"PMC_33390847","title":"HES1 promotes breast cancer stem cells by elevating Slug in triple-negative breast cancer.","date":"2021","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33390847","citation_count":25,"is_preprint":false},{"pmid":"21984123","id":"PMC_21984123","title":"Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.","date":"2011","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21984123","citation_count":25,"is_preprint":false},{"pmid":"23277114","id":"PMC_23277114","title":"The expression of NOTCH2, HES1 and SOX9 during mouse retinal development.","date":"2012","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/23277114","citation_count":24,"is_preprint":false},{"pmid":"25326132","id":"PMC_25326132","title":"Regulation of a Notch3-Hes1 pathway and protective effect by a tocopherol-omega alkanol chain derivative in muscle atrophy.","date":"2014","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25326132","citation_count":24,"is_preprint":false},{"pmid":"23207146","id":"PMC_23207146","title":"PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis.","date":"2012","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/23207146","citation_count":23,"is_preprint":false},{"pmid":"33531431","id":"PMC_33531431","title":"Hes1 overexpression leads to expansion of embryonic neural stem cell pool and stem cell reservoir in the postnatal brain.","date":"2021","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33531431","citation_count":23,"is_preprint":false},{"pmid":"33622250","id":"PMC_33622250","title":"The NOTCH-HES-1 axis is involved in promoting Th22 cell differentiation.","date":"2021","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33622250","citation_count":22,"is_preprint":false},{"pmid":"24098462","id":"PMC_24098462","title":"The jagged-2/notch-1/hes-1 pathway is involved in intestinal epithelium regeneration after intestinal ischemia-reperfusion injury.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24098462","citation_count":22,"is_preprint":false},{"pmid":"34440505","id":"PMC_34440505","title":"Rutin Mediated Apoptotic Cell Death in Caski Cervical Cancer Cells via Notch-1 and Hes-1 Downregulation.","date":"2021","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34440505","citation_count":22,"is_preprint":false},{"pmid":"34703994","id":"PMC_34703994","title":"HES1 protein oscillations are necessary for neural stem cells to exit from quiescence.","date":"2021","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/34703994","citation_count":21,"is_preprint":false},{"pmid":"31015298","id":"PMC_31015298","title":"Hes1 attenuates type I IFN responses via VEGF-C and WDFY1.","date":"2019","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31015298","citation_count":20,"is_preprint":false},{"pmid":"28464358","id":"PMC_28464358","title":"miR-1297 regulates neural stem cell differentiation and viability through controlling Hes1 expression.","date":"2017","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/28464358","citation_count":20,"is_preprint":false},{"pmid":"35732696","id":"PMC_35732696","title":"Medial prefrontal cortex Notch1 signalling mediates methamphetamine-induced psychosis via Hes1-dependent suppression of GABAB1 receptor expression.","date":"2022","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/35732696","citation_count":20,"is_preprint":false},{"pmid":"34224859","id":"PMC_34224859","title":"Melatonin attenuates aortic oxidative stress injury and apoptosis in STZ-diabetes rats by Notch1/Hes1 pathway.","date":"2021","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/34224859","citation_count":19,"is_preprint":false},{"pmid":"29126793","id":"PMC_29126793","title":"Inhibition of Notch1/Hes1 signaling pathway improves radiosensitivity of colorectal cancer cells.","date":"2017","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29126793","citation_count":19,"is_preprint":false},{"pmid":"21495212","id":"PMC_21495212","title":"Hes1/Hes5 gene inhibits differentiation via down-regulating Hash1 and promotes proliferation in cervical carcinoma cells.","date":"2010","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/21495212","citation_count":19,"is_preprint":false},{"pmid":"18636433","id":"PMC_18636433","title":"TGF-alpha induces upregulation and nuclear translocation of Hes1 in glioma cell.","date":"2008","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/18636433","citation_count":19,"is_preprint":false},{"pmid":"28675662","id":"PMC_28675662","title":"Separate and coincident expression of Hes1 and Hes5 in the developing mouse eye.","date":"2017","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/28675662","citation_count":17,"is_preprint":false},{"pmid":"31109645","id":"PMC_31109645","title":"SP promotes cell proliferation in esophageal squamous cell carcinoma through the NK1R/Hes1 axis.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31109645","citation_count":17,"is_preprint":false},{"pmid":"33067264","id":"PMC_33067264","title":"Hes1 Is Essential in Proliferating Ductal Cell-Mediated Development of Intrahepatic Cholangiocarcinoma.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33067264","citation_count":16,"is_preprint":false},{"pmid":"36321463","id":"PMC_36321463","title":"HES1 promoter activation dynamics reveal the plasticity, stemness and heterogeneity in neuroblastoma cancer stem cells.","date":"2022","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/36321463","citation_count":16,"is_preprint":false},{"pmid":"16322473","id":"PMC_16322473","title":"Overexpression of HES-1 is not sufficient to impose T-cell differentiation on human hematopoietic stem cells.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16322473","citation_count":16,"is_preprint":false},{"pmid":"35699595","id":"PMC_35699595","title":"RNF144B stimulates the proliferation and inhibits the apoptosis of human spermatogonial stem cells via the FCER2/NOTCH2/HES1 pathway and its abnormality is associated with azoospermia.","date":"2022","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35699595","citation_count":16,"is_preprint":false},{"pmid":"9790494","id":"PMC_9790494","title":"Genetic elements regulating HES-1 induction in Wnt-1-transformed PC12 cells.","date":"1998","source":"Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/9790494","citation_count":15,"is_preprint":false},{"pmid":"31733832","id":"PMC_31733832","title":"Somatostatin stimulates colonic MUC2 expression through SSTR5-Notch-Hes1 signaling pathway.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31733832","citation_count":14,"is_preprint":false},{"pmid":"23489689","id":"PMC_23489689","title":"Jagged-1-HES-1 signaling inhibits the differentiation of TH17 cells via ROR gammat.","date":"2013","source":"Journal of biological regulators and homeostatic agents","url":"https://pubmed.ncbi.nlm.nih.gov/23489689","citation_count":14,"is_preprint":false},{"pmid":"30867133","id":"PMC_30867133","title":"Synchronization of Hes1 oscillations coordinates and refines condensation formation and patterning of the avian limb skeleton.","date":"2019","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/30867133","citation_count":14,"is_preprint":false},{"pmid":"34897944","id":"PMC_34897944","title":"RASSF1A disrupts the NOTCH signaling axis via SNURF/RNF4-mediated ubiquitination of HES1.","date":"2021","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/34897944","citation_count":14,"is_preprint":false},{"pmid":"29491143","id":"PMC_29491143","title":"Hairy and enhancer of split 1 (HES1) protects cells from endoplasmic reticulum stress-induced apoptosis through repression of .","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29491143","citation_count":14,"is_preprint":false},{"pmid":"34270850","id":"PMC_34270850","title":"ETV4 transcriptionally activates HES1 and promotes Stat3 phosphorylation to promote malignant behaviors of colon adenocarcinoma.","date":"2021","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/34270850","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48048,"output_tokens":10346,"usd":0.149667,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20720,"output_tokens":7192,"usd":0.1417,"stage2_stop_reason":"end_turn"},"total_usd":0.291367,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Hes1 and Hes5 are essential downstream effectors of Notch signaling in mammalian neuronal differentiation; constitutively active Notch fails to inhibit neuronal differentiation in Hes1/Hes5 double-null neural precursor cells, placing Hes1 genetically downstream of Notch in this pathway.\",\n      \"method\": \"Retroviral misexpression of constitutively active Notch in wild-type, Hes1-null, Hes5-null, and Hes1/Hes5 double-null mouse neural precursor cells; genetic epistasis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic epistasis with double-null rescue, replicated across multiple genotypes in a single rigorous study\",\n      \"pmids\": [\"10205173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Delta-1 activation of Notch-1 results in transcriptional upregulation of HES-1; this transactivation requires both Kuzbanian metalloprotease activity and RBP-J (CSL) transcription factor activity, placing HES-1 as a direct transcriptional target downstream of the Delta-1/Notch-1/RBP-J axis.\",\n      \"method\": \"Two-cell coculture assay with Notch-1-expressing cells and Delta-1-expressing cells; HES-1 promoter-luciferase reporter; endogenous HES-1 mRNA measurement; dominant-negative Kuzbanian and RBP-J inhibition\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (reporter assay, endogenous mRNA, genetic inhibition of pathway components) in one study\",\n      \"pmids\": [\"9819428\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hes1 deficiency in mice causes depletion of pancreatic epithelial precursors through accelerated differentiation into endocrine cells, with upregulation of multiple bHLH proneural/endocrine factors, establishing Hes1 as a general negative regulator of endodermal endocrine differentiation that keeps precursor cells undifferentiated.\",\n      \"method\": \"Hes1 knockout mouse analysis; histology; expression analysis of bHLH components in pancreas, stomach and gut\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean loss-of-function mouse model with defined cellular phenotype, replicated across multiple tissue types\",\n      \"pmids\": [\"10615124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hes6 suppresses Hes1 transcriptional repression without itself binding DNA; Hes6 also relieves Hes1-mediated inhibition of Mash1-E47 heterodimer transcriptional activity. Loop-region swapping between Hes1 and Hes6 partially exchanges their specific functions, indicating the loop region is functionally important.\",\n      \"method\": \"DNA binding assays; transcriptional reporter assays; retroviral misexpression in developing retina; domain-swap mutagenesis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro transcriptional assays plus mutagenesis plus in vivo retroviral misexpression, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"10851137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hes1 functions as a bHLH transcriptional repressor that antagonizes positive bHLH factors (e.g., Mash1); misexpression of Hes1 inhibits differentiation and maintains precursor/proliferative state, while loss of Hes1 leads to upregulation of positive bHLH genes and premature differentiation across multiple tissues (brain, eye, pancreas, thymus).\",\n      \"method\": \"Hes1 knockout mouse model; Hes1 misexpression experiments; expression analysis of downstream bHLH targets\",\n      \"journal\": \"Molecules and cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function and gain-of-function across multiple tissue types with defined molecular targets\",\n      \"pmids\": [\"10774739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Mathematical modeling demonstrates that the observed ~2-hour oscillatory expression of Hes1 mRNA and protein is driven by transcriptional time delays inherent in the negative autoregulatory feedback loop of Hes1; oscillation period is determined by the delay and the protein/mRNA half-lives.\",\n      \"method\": \"Mathematical modeling of delay differential equations constrained by experimental mRNA and protein half-life data\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 4 / Moderate — computational modeling informed by experimental data, no direct experimental manipulation; moderate because it is consistent with multiple subsequent experimental studies\",\n      \"pmids\": [\"12932324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Hes-1 directly represses E2F-1 transcription through a CACGAG site in the E2F-1 promoter, inhibiting G1/S-phase transition and estrogen/heregulin-beta1-stimulated proliferation in breast cancer cells.\",\n      \"method\": \"Tetracycline-regulated HES-1 expression; dominant-negative HES-1; luciferase reporter with E2F-1 promoter and CACGAG site mutation; cell cycle analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — promoter-reporter with site-directed mutation plus dominant-negative validation plus cell cycle readout, single lab multiple orthogonal methods\",\n      \"pmids\": [\"15467735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HES-1 is a novel transcriptional target of the aryl hydrocarbon receptor (AhR); AhR and HES-1 protein compete for binding to a composite HES/XRE element at -48/-42 in the HES-1 promoter, establishing a negative autoregulatory loop where HES-1 represses its own AhR-induced transcription.\",\n      \"method\": \"Actinomycin D transcription inhibition; luciferase reporter with HES-1 promoter; identification and mutation of XRE/HES composite element; protein competition assays\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays with functional element identification, single lab, multiple methods\",\n      \"pmids\": [\"14722248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Notch/Hes-1 signaling blocks adipogenesis by suppressing C/EBPalpha and PPARgamma2 induction; constitutive Hes-1 expression mimics Jagged1-induced differentiation block, which can be rescued by ectopic C/EBPalpha or PPARgamma2. Additionally, Hes-1 down-regulates DLK/Pref-1 transcription, revealing a dual role in adipocyte development.\",\n      \"method\": \"Notch ligand (Jagged1) exposure of 3T3-L1 cells; retroviral Hes-1 expression; siRNA knockdown of Hes-1; retroviral rescue with C/EBPalpha and PPARgamma2\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function, loss-of-function, and rescue experiments with defined molecular targets, single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"15060169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Hes1 directly promotes progenitor cell proliferation by transcriptionally repressing the cyclin-dependent kinase inhibitor p27Kip1 through binding to class C sites in the p27Kip1 promoter; Hes1-deficient mouse tissues show elevated p27Kip1 transcripts.\",\n      \"method\": \"Tetracycline-inducible Hes1 expression; p27Kip1 promoter-reporter assays; chromatin immunoprecipitation; retinoic acid-induced Hes1 repression model; Hes1-null mouse tissue analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP demonstrating direct promoter binding, promoter reporter, inducible expression system, and confirmation in knockout mouse tissues\",\n      \"pmids\": [\"15870295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Persistent and high-level Hes1 expression constitutively represses proneural bHLH gene (Mash1) expression in boundary cells of the developing CNS, forming neuron-free organizing centers; loss of Hes1/Hes3/Hes5 causes ectopic proneural gene expression and neurogenesis at boundaries.\",\n      \"method\": \"Hes1/Hes3/Hes5 compound knockout mice; retroviral persistent Hes1 expression in neural progenitors; in situ hybridization for Hes1 and Mash1\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — compound knockout with gain-of-function rescue, defined molecular target (Mash1 repression), multiple approaches\",\n      \"pmids\": [\"16728479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HES1 inhibits hematopoietic progenitor cell cycling in a manner requiring its DNA-binding domain; HES1 overexpression upregulates p21(Cip1/Waf1) and inhibits cell expansion without inducing apoptosis or altering differentiation, while preserving long-term HSC reconstituting activity.\",\n      \"method\": \"Lentiviral overexpression of wild-type HES1 vs. DNA-binding domain deletion mutant (BHES1) in human CD34+ and mouse HSCs; in vitro cycling assays; in vivo repopulation assays\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-deletion mutagenesis with in vitro and in vivo functional readouts, single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"16513761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Hes1 directly represses p57 transcription in pancreatic progenitors to maintain their cell cycle progression; Hes1 inactivation upregulates p57, causing cell cycle arrest and precocious differentiation. p57/Hes1 double-null embryos show expanded progenitor populations, confirming that p57 is a direct Hes1 target mediating progenitor self-renewal.\",\n      \"method\": \"Hes1 knockout mice; p57/Hes1 double knockout mice; expression analysis; genetic epistasis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis via double knockout with defined phenotypic rescue, replicated across genotypes\",\n      \"pmids\": [\"16899237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Hes-1 expression is elevated in confluent endothelial cells through a Notch-independent mechanism involving c-Jun N-terminal kinase (JNK) signaling, demonstrating that HES-1 can be regulated by a non-Notch pathway.\",\n      \"method\": \"Comparison of Notch activation levels vs. Hes-1 protein in proliferating vs. confluent endothelial cells; pharmacological JNK inhibition; Western blot\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pharmacological inhibition with protein-level readout, single lab, limited mechanistic depth\",\n      \"pmids\": [\"16732296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Stat3 oscillations, induced by serum, drive oscillatory Hes1 expression by regulating Hes1 protein half-life; coupled Stat-Hes1 oscillations are required for efficient G1 cell cycle progression and cell proliferation.\",\n      \"method\": \"Serum stimulation assays; identification of Stat3/Smad1 oscillations with their inhibitors Socs3/Smad6; Hes1 protein half-life measurements; loss of Hes1 oscillation with G1 phase analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple signaling components identified with functional cell cycle readout, single lab\",\n      \"pmids\": [\"17592117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Id proteins directly interact with Hes1 protein and release its negative autoregulatory feedback (self-repression) without interfering with Hes1 repression of other target genes, thereby sustaining Hes1 expression levels in early neural tube and maintaining neural stem cell pools.\",\n      \"method\": \"Co-immunoprecipitation of Id2 with Hes1; Id2 overexpression in chick hindbrain; Id1/Id3 double knockout mice; Id1-3 RNAi in chick embryos; Hes1 expression analysis\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct protein interaction (Co-IP), loss-of-function (double KO and RNAi), and gain-of-function with mechanistic dissection, replicated across species\",\n      \"pmids\": [\"17681138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HES1 directly represses 5-HT1A receptor transcription through a HES consensus site in the promoter; HES1 represses at both C(-1019) and G(-1019) alleles (unlike HES5 which is allele-selective). Loss of HES1 in knockout mice elevates 5-HT1A receptor expression in E12.5 hindbrain and midbrain, confirming HES1 is required for correct developmental 5-HT1A expression.\",\n      \"method\": \"HES1 promoter-reporter assays with consensus site mutation; HES1 overexpression and HES6 co-expression experiments; HES1-/- mouse 5-HT1A expression analysis\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — reporter assay with site mutation, confirmed in knockout mice, single lab multiple methods\",\n      \"pmids\": [\"18499474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HES1 directly interacts with PARP1 in B-cell ALL; HES1-PARP1 interaction inhibits HES1 transcriptional function and activates PARP1, leading to PARP1 auto-ADP-ribosylation, NAD+ consumption, ATP depletion, and apoptosis-inducing factor nuclear translocation, causing apoptosis specifically in B-ALL but not T-ALL.\",\n      \"method\": \"Co-immunoprecipitation of HES1 and PARP1; PARP1 activation assays; NAD+/ATP measurements; AIF nuclear translocation assay; cell viability in B-ALL vs. T-ALL\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with functional biochemical readouts (PARP1 activation, NAD+, ATP, AIF translocation) and cell-type specificity, single lab multiple orthogonal methods\",\n      \"pmids\": [\"21224467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GATA-1, facilitated by Ikaros, directly represses Hes1 gene expression in erythroid cells by recruiting FOG-1, NuRD/MI-2 ATPase, GFI1B, and the Polycomb repressive complex 2 (PRC2/EZH2) to the Hes1 locus; EZH2-mediated H3K27 methylation is required for transient Hes1 repression during erythroid differentiation.\",\n      \"method\": \"RNAi depletion of HES1 in mouse erythroleukemia cells; Ikaros-deficient mouse erythroid cells; ChIP for GATA-1, FOG-1, MI-2, GFI1B, EZH2 at Hes1 locus; EZH2 requirement assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP mapping of multiple chromatin regulators at Hes1 locus, loss-of-function with defined epigenetic mechanism, multiple orthogonal methods\",\n      \"pmids\": [\"22778136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hes1 directly binds to the promoter region of the FLT3 gene and represses its transcription; Hes1 deletion in MLL-AF9 leukemia cells upregulates FLT3, enhances FLT3L-stimulated ERK phosphorylation and proliferation, and FLT3 inhibition reverses Hes1-null AML cell proliferation.\",\n      \"method\": \"ChIP of Hes1 at FLT3 promoter; FLT3 promoter-reporter assays; Hes1 knockout in MLL-AF9 AML model; ERK phosphorylation assays; FLT3 inhibitor treatment\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP with promoter reporter, functional knockout with defined downstream signaling readout, single lab multiple methods\",\n      \"pmids\": [\"25234168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HES1 directly represses BBC3 (encoding the pro-apoptotic PUMA) in T-ALL cells, thereby promoting tumor cell survival downstream of NOTCH1 signaling.\",\n      \"method\": \"HES1 knockdown in T-ALL; BBC3/PUMA expression analysis; functional apoptosis assays; ChIP at BBC3 locus\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus knockdown with apoptosis readout, single lab\",\n      \"pmids\": [\"25784680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Ubiquitin-specific proteases Usp27x, Usp22, and Usp51 deubiquitinate and stabilize Hes1 protein; Usp22 knockdown shortens Hes1 half-life, delays Hes1 oscillations, and enhances neuronal differentiation in developing mouse brain, while Usp27x misexpression reduces neuronal differentiation.\",\n      \"method\": \"Hes1-specific antibody pulldown from mouse ES cells for deubiquitinase purification; deubiquitination assays; Usp22 knockdown (protein half-life, oscillation period measurement); Usp27x misexpression in developing brain\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — biochemical deubiquitination assay, protein half-life measurement, in vivo functional validation, single lab multiple orthogonal methods\",\n      \"pmids\": [\"25846153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hes1 suppresses inflammatory gene expression (specifically Cxcl1) by inhibiting recruitment of the positive transcription-elongation complex P-TEFb to the Cxcl1 locus, thereby preventing RNA Pol II Ser2 phosphorylation and productive elongation — a post-initiation mechanism distinct from typical pre-initiation transcriptional repression.\",\n      \"method\": \"Hes1 knockout macrophages; in vivo neutrophil recruitment assays; ChIP for P-TEFb and RNA Pol II Ser2 phosphorylation at Cxcl1; inflammatory arthritis model\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP mechanistic evidence for novel elongation-based repression plus in vivo loss-of-function with defined pathway readout, single rigorous study\",\n      \"pmids\": [\"27322654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hes1 attenuates type I IFN production not by directly repressing IFN genes, but by transcriptionally activating VEGF-C expression (a rare case of Hes1 acting as a transcriptional activator); VEGF-C induction suppresses the TLR upstream adaptor WDFY1, thereby dampening TLR signaling and IFN production.\",\n      \"method\": \"Hes1-deficient mice; genome-wide Hes1 ChIP-seq; VEGF-C and WDFY1 expression assays; ENCEPHALOMYOCARDITIS virus infection model; lupus nephritis model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq with functional in vivo loss-of-function validation across multiple disease models, single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"31015298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CREB and Sirt-1 cooperatively regulate Hes1 promoter activity in neural stem cells in response to glucose availability: excess glucose promotes Sirt-1-dependent repression of the Hes1 promoter, while low glucose favors CREB replacement of Sirt-1 at Hes1 chromatin, enhancing Hes1 expression and proliferation.\",\n      \"method\": \"CREB-deficient NSCs; glucose manipulation; ChIP for CREB and Sirt-1 at Hes1 promoter; Hes1 promoter-reporter assays; NSC proliferation assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating competitive occupancy plus reporter assay plus functional NSC readout, single lab multiple methods\",\n      \"pmids\": [\"26804914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Hes1 directly binds the GADD34 promoter and represses GADD34 expression during ER stress, protecting cells from apoptosis; HES1 depletion increases GADD34 expression and cell death during ER stress in a GADD34-dependent manner.\",\n      \"method\": \"HES1 depletion (siRNA/shRNA) in mouse and human cells; ChIP of HES1 at GADD34 promoter; GADD34 expression measurement; cell death assays with GADD34 dependency\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP of direct promoter binding, loss-of-function with epistatic GADD34 dependency, validated in multiple cell types\",\n      \"pmids\": [\"29491143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In quiescent adult neural stem cells, Hes1 oscillates at higher levels than in active NSCs, keeping Ascl1 continuously suppressed; inactivation of Hes1 and related genes upregulates Ascl1 and increases neurogenesis causing NSC depletion, while sustained Hes1 overexpression represses Ascl1 and maintains quiescence.\",\n      \"method\": \"Hes1 conditional knockout mice (with Hes3/Hes5 compound deletion); live imaging of Hes1-Venus and Ascl1-Venus reporters in adult brain NSCs; sustained Hes1 overexpression; Ascl1 oscillation induction\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — live reporter imaging of oscillation dynamics, compound knockout, gain-of-function, multiple orthogonal approaches\",\n      \"pmids\": [\"30862661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Hes1 oscillates in activated muscle stem cells and drives oscillatory MyoD expression; ablation of the Hes1 oscillator disrupts MyoD oscillations, leads to sustained MyoD expression and premature differentiation, impairing muscle stem cell maintenance and muscle growth/repair.\",\n      \"method\": \"Live imaging of Hes1 and MyoD reporters in dispersed cells, single muscle fiber cultures, and muscle biopsies; conditional Hes1 ablation; muscle regeneration assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — live imaging of oscillations with conditional knockout showing mechanistic link to MyoD dynamics and functional muscle phenotype\",\n      \"pmids\": [\"30862660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Mutant KRAS-induced sustained Hes1 expression (via MAPK/ERK signaling) is required for acinar-to-ductal metaplasia (ADM) to progress to pancreatic intraepithelial neoplasia (PanIN); Hes1 ablation in KrasG12D mice forces ADM to re-differentiate back to acinar cells and prevents PDAC formation.\",\n      \"method\": \"Elastase1-CreERT2;KrasG12D mouse model with Hes1 genetic ablation; KrasG12D;Trp53R172H;Hes1-null PDAC model; gene expression analysis; lineage tracing\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional genetic ablation in multiple in vivo cancer models with lineage tracing and molecular characterization\",\n      \"pmids\": [\"30705405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Epithelial Hes1 deletion modulates ciliogenesis and Smoothened ciliary accumulation in response to Shh; Hes1 potentiates hedgehog signaling in hair follicle stem cells to enable anagen initiation and HFSC self-renewal during repetitive depilation.\",\n      \"method\": \"Epithelial Hes1 conditional knockout mice; microarray gene profiling of HFSCs; primary keratinocyte ciliogenesis assays; Smoothened agonist rescue experiments\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with molecular rescue and in vitro ciliogenesis assay, single lab\",\n      \"pmids\": [\"31721388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Hes1 deficiency in hematopoietic cells leads to HSC exhaustion under replicative stress by upregulating PPARgamma signaling and augmenting fatty acid oxidation (FAO); PPARgamma targeting or FAO inhibition rescues repopulating defects of Hes1-null HSCs by restoring quiescence.\",\n      \"method\": \"Hes1-flox/Vav1-Cre conditional knockout mice; bone marrow transplantation/stress hematopoiesis assays; transcriptome analysis; FAO measurement; pharmacological PPARgamma and FAO inhibition\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional knockout with pharmacological rescue identifying specific metabolic pathway, multiple orthogonal methods\",\n      \"pmids\": [\"32129527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Robust Hes1 oscillations (high amplitude) are required for normal NPC proliferation and correct timing of neurogenesis; knock-in mice with dampened Hes1 oscillations (type-1 mutation) display smaller brains, decreased NPC proliferation, increased cell death, and upregulated proneural genes, while elongated-period (type-2) mutants are normal.\",\n      \"method\": \"Hes1 knock-in mice with shortened (type-1) and elongated (type-2) oscillation periods; brain morphometry; EdU proliferation assays; TUNEL apoptosis assays; proneural gene expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent knock-in alleles with opposing oscillation alterations allowing internal control, multiple phenotypic readouts\",\n      \"pmids\": [\"32094111\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RASSF1A acts as a scaffold for the SUMO-targeted E3 ubiquitin ligase SNURF/RNF4 to target HES1 for proteasomal degradation; RASSF1A loss stabilizes HES1 protein, promoting tumor dedifferentiation, independently of RASSF1A's role in the Hippo pathway.\",\n      \"method\": \"Co-immunoprecipitation of RASSF1A with HES1 and SNURF/RNF4; ubiquitination assays; proteasome inhibition; RASSF1A depletion with HES1 protein stability measurement; GSI sensitivity assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying scaffold interaction, biochemical ubiquitination assays, functional consequences demonstrated, single lab multiple methods\",\n      \"pmids\": [\"34897944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HES1 oscillatory expression is specifically required for neural stem cells to exit quiescence; persistent (non-oscillatory) HES1 expression at physiological levels does not affect entry into quiescence or proliferation but specifically impedes quiescence exit.\",\n      \"method\": \"BMP4-induced quiescence in embryonic NSCs; persistent HES1 expression under moderate-strength promoter to override oscillations while maintaining total level; cell cycle and quiescence exit assays\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — specific manipulation of HES1 dynamics (oscillatory vs. persistent) at matched levels, single lab, functional quiescence assays\",\n      \"pmids\": [\"34703994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In the medial prefrontal cortex, Hes1 directly binds to the GABAB1 receptor promoter and represses its transcription; Notch1-Hes1 signaling negatively regulates GABAB1 receptor expression and thereby modulates neuronal activity in methamphetamine-induced psychosis.\",\n      \"method\": \"ChIP of Hes1 at GABAB1 receptor promoter; Notch1 genetic and pharmacological manipulation; GABAB1 receptor expression and behavioral assays\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP of direct promoter binding with in vivo functional behavioral readout, single lab\",\n      \"pmids\": [\"35732696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HES1 transcriptionally activates immunoglobulin-binding protein 1 (IGBP1) expression, which in turn promotes protein phosphatase 6 (PP6) expression and inhibits its ubiquitination; this HES1-IGBP1-PP6 axis is dysfunctional in psoriasis, and L-menthol upregulates HES1 by preventing its proteasomal degradation.\",\n      \"method\": \"Target identification screen with L-menthol; ChIP of HES1 at IGBP1 promoter; HES1 knockdown/overexpression; PP6 ubiquitination assays; HES1 protein stability assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP of direct transcriptional activation with downstream functional validation, single lab\",\n      \"pmids\": [\"36535970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Oscillatory Hes1 expression directly represses p21 (Cdkn1a) to promote NSC proliferation; however, sustained Hes1 overexpression paradoxically upregulates p21 by repressing Dusp7 (a phosphatase for p-Erk) and increasing p-Erk levels, which indirectly elevates p21. Thus, Hes1 differentially controls cell proliferation depending on its expression dynamics.\",\n      \"method\": \"Oscillatory vs. sustained Hes1 expression in mouse NSCs; p21 expression measurement; Dusp7 expression analysis; p-Erk level measurement; proliferation assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional dissection of expression dynamics with molecular intermediates (Dusp7, p-Erk), single lab, multiple signaling readouts\",\n      \"pmids\": [\"37200191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The human HES1 gene (HRY) encodes a bHLH protein with only four amino acid differences from the rat homolog; the coding region is contained within four exons; the locus was mapped by FISH to chromosome 3q28-q29.\",\n      \"method\": \"Genomic cloning; sequence analysis; fluorescence in situ hybridization (FISH)\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct chromosomal localization by FISH and gene structure by sequencing, single study\",\n      \"pmids\": [\"8020957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Forced HES-1 expression in hippocampal neurons inhibits intrinsic and NGF-induced neurite outgrowth and blocks MASH-1-activated differentiation; even a non-DNA-binding mutant of HES-1 retains the ability to repress MASH-1-dependent transcription, indicating a DNA-binding-independent repression mechanism.\",\n      \"method\": \"Retroviral HES-1 and MASH-1 expression in TrkA-transfected hippocampal neurons; NGF-induced differentiation assay; non-DNA-binding HES-1 mutant co-expression; reporter assays\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with domain mutant revealing DNA-binding-independent repression, single lab multiple approaches\",\n      \"pmids\": [\"10336252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MYEOV interacts directly with SOX9 in the nucleus and enhances SOX9 DNA-binding ability to the HES1 enhancer, promoting HES1 transcription; HES1 knockdown partially abolishes MYEOV oncogenic effects in pancreatic cancer.\",\n      \"method\": \"Co-immunoprecipitation of MYEOV and SOX9; ChIP of SOX9 at HES1 enhancer; HES1 reporter assays; HES1 knockdown rescue experiments\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ChIP plus functional rescue, single lab\",\n      \"pmids\": [\"32879444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HES1 directly binds the IGF2BP2 promoter and promotes IGF2BP2 expression; IGF2BP2 then recognizes and binds the m6A site in GLUT1 mRNA, enhancing its stability and promoting aerobic glycolysis in colorectal cancer cells.\",\n      \"method\": \"ChIP-PCR of HES1 at IGF2BP2 promoter; dual-luciferase reporter assay; HES1/IGF2BP2 knockdown; GLUT1 mRNA stability measurement; m6A site analysis\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with reporter assay and downstream RNA stability mechanism, single lab\",\n      \"pmids\": [\"37957183\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HES1 is a bHLH transcriptional repressor that functions as the primary downstream effector of Notch signaling — activated through the Delta/Jagged → Notch → RBP-J axis — and suppresses proneural/pro-differentiation bHLH factors (Mash1/Ascl1, Math5) and cell-cycle inhibitors (p27Kip1, p57, p21) by directly binding their promoters; its expression oscillates with ~2–3 hour periodicity driven by transcriptional time-delay negative autoregulation, and these oscillations are functionally distinct from sustained high-level expression — oscillatory Hes1 promotes stem cell proliferation while sustained Hes1 enforces quiescence or boundary identity; Hes1 protein stability is regulated by ubiquitin/proteasome degradation (counteracted by deubiquitinases Usp27x/Usp22/Usp51 and promoted by RASSF1A-scaffolded SNURF/RNF4); Hes1 also suppresses inflammatory responses by blocking P-TEFb-dependent transcription elongation at Cxcl1 and attenuates TLR/type I IFN signaling by transcriptionally activating VEGF-C to suppress WDFY1; non-Notch inputs including JNK, MAPK/ERK (via Kras), Stat3, CREB/Sirt-1, and AhR can regulate Hes1 expression independently of the canonical pathway.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HES1 is a basic helix-loop-helix transcriptional repressor that operates as the principal downstream effector of Notch signaling, governing the balance between progenitor maintenance and differentiation across neural, pancreatic, hematopoietic, and muscle lineages [#0, #1, #4]. Delta-1 engagement of Notch-1 drives RBP-J (CSL)-dependent transcriptional induction of HES1, and HES1 together with HES5 is genetically required for Notch to block neuronal differentiation [#0, #1]. The canonical output of HES1 is repression of proneural/pro-differentiation bHLH factors such as Mash1/Ascl1, which keeps precursor cells undifferentiated and, when lost, causes premature differentiation and progenitor depletion in multiple tissues [#2, #4, #10, #26]. HES1 sustains progenitor proliferation by directly repressing cell-cycle inhibitors — p27Kip1, p57, p21/Cip1, and E2F-1 — through binding to class C/CACGAG sites in their promoters [#6, #9, #11, #12]. A defining feature of HES1 is that its expression oscillates with ~2-hour periodicity generated by transcriptional time-delay negative autoregulation, and these oscillations are functionally distinct from sustained high-level expression: oscillatory HES1 keeps Ascl1 (and MyoD) suppressed to promote stem-cell proliferation and quiescence exit, whereas persistent high-level HES1 enforces sustained Ascl1 repression, quiescence, or boundary (neuron-free) identity [#5, #10, #26, #27, #31, #33]. HES1 protein levels are set by ubiquitin/proteasome turnover, antagonized by the deubiquitinases Usp27x/Usp22/Usp51 and promoted by RASSF1A-scaffolded SNURF/RNF4-mediated degradation [#21, #32]. Beyond progenitor control, HES1 restrains inflammatory and innate-immune responses, blocking P-TEFb-dependent transcription elongation at Cxcl1 and, atypically acting as an activator, inducing VEGF-C to suppress the TLR adaptor WDFY1 [#22, #23]. HES1 expression is additionally tuned by non-Notch inputs including JNK, oncogenic KRAS/MAPK-ERK, Stat3, CREB/Sirt-1, and the aryl hydrocarbon receptor [#7, #13, #14, #24, #28].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing the human HES1 gene structure and chromosomal location provided the molecular foundation for studying it as a conserved bHLH factor.\",\n      \"evidence\": \"Genomic cloning, sequencing, and FISH mapping of human HRY/HES1\",\n      \"pmids\": [\"8020957\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not address function or regulation\", \"No protein interaction or target data\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defining HES1 as a direct transcriptional target of the Delta/Notch/RBP-J axis answered how Notch signal is converted into a transcriptional output.\",\n      \"evidence\": \"Two-cell coculture with HES1 promoter-luciferase reporter, endogenous mRNA measurement, and dominant-negative Kuzbanian/RBP-J inhibition\",\n      \"pmids\": [\"9819428\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not show which downstream genes HES1 then regulates\", \"Cell-type generality of RBP-J dependence not tested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Genetic epistasis placed HES1/HES5 downstream of Notch as obligatory effectors, showing Notch cannot block neuronal differentiation without them.\",\n      \"evidence\": \"Constitutively active Notch misexpression in Hes1/Hes5 single- and double-null neural precursors\",\n      \"pmids\": [\"10205173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DNA targets mediating the block not defined here\", \"Redundancy with other HES/HEY factors not fully resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that a non-DNA-binding HES-1 mutant still represses MASH-1 revealed a DNA-binding-independent mode of repression alongside its canonical promoter binding.\",\n      \"evidence\": \"Retroviral HES-1/MASH-1 expression with non-DNA-binding mutant in hippocampal neurons and reporter assays\",\n      \"pmids\": [\"10336252\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of DNA-binding-independent repression unresolved\", \"Relative contribution of each mode in vivo unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Loss- and gain-of-function across multiple tissues established HES1 as a general repressor of proneural/endocrine bHLH factors that keeps precursors undifferentiated.\",\n      \"evidence\": \"Hes1 knockout mice with histology/expression analysis in pancreas, gut, brain, eye, thymus and misexpression studies\",\n      \"pmids\": [\"10615124\", \"10774739\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect target regulation not fully separated\", \"Mechanism of repression at each target undefined at this stage\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identifying Hes6 as a HES1 antagonist and mapping the loop region defined how HES1 repressive activity itself is modulated.\",\n      \"evidence\": \"DNA-binding/reporter assays, retinal retroviral misexpression, and loop-region domain swaps\",\n      \"pmids\": [\"10851137\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Hes6 inhibition not resolved\", \"In vivo physiological relevance limited to retina\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defining HES1 control of E2F-1 and adipogenic regulators (C/EBPalpha, PPARgamma2, DLK/Pref-1) connected HES1 repression directly to cell-cycle entry and lineage commitment.\",\n      \"evidence\": \"Inducible/dominant-negative HES1, promoter-reporter with site mutation, and Jagged1/Hes1 gain- and loss-of-function with rescue in 3T3-L1 cells\",\n      \"pmids\": [\"15467735\", \"15060169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct promoter binding to adipogenic genes not all demonstrated\", \"Tissue specificity of the E2F-1 axis untested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that AhR transcriptionally induces HES1, with HES1 repressing its own AhR-driven transcription, introduced a non-Notch input and an autoregulatory loop.\",\n      \"evidence\": \"Promoter-reporter assays with XRE/HES composite element identification and protein competition assays\",\n      \"pmids\": [\"14722248\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological context of AhR-HES1 loop not established in vivo\", \"Single-lab reporter-based evidence\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"ChIP-level evidence that HES1 directly represses p27Kip1 explained mechanistically how HES1 promotes progenitor proliferation.\",\n      \"evidence\": \"Inducible Hes1, p27Kip1 promoter-reporter, ChIP, and Hes1-null tissue analysis\",\n      \"pmids\": [\"15870295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether p27 repression is sufficient for proliferation control not isolated\", \"Interplay with other CDK inhibitor targets not addressed here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Extending direct repression to p57 (with double-knockout epistasis), p21, and demonstrating boundary-cell roles unified HES1 control of progenitor self-renewal and organizer identity.\",\n      \"evidence\": \"Hes1/p57 and Hes1/Hes3/Hes5 compound knockouts, DNA-binding-domain-dependent HSC assays, and persistent Hes1 misexpression\",\n      \"pmids\": [\"16899237\", \"16513761\", \"16728479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of each CDK inhibitor target differs by tissue\", \"How sustained vs dynamic expression dictates boundary vs progenitor fate not yet mechanistically defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying JNK-driven, Notch-independent HES1 induction in confluent endothelium broadened the regulatory inputs beyond the canonical pathway.\",\n      \"evidence\": \"Proliferating vs confluent endothelial comparison with pharmacological JNK inhibition and Western blot\",\n      \"pmids\": [\"16732296\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct JNK-to-HES1 transcriptional mechanism not mapped\", \"Pharmacological inhibition only; limited mechanistic depth\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Mathematical modeling plus identification of Id-protein and Stat3 inputs explained how the HES1 oscillator is generated and how its autoregulation and protein half-life are tuned.\",\n      \"evidence\": \"Delay differential equation modeling constrained by half-life data; Id2 Co-IP with loss/gain-of-function; serum-induced Stat3 oscillation and Hes1 half-life measurement\",\n      \"pmids\": [\"12932324\", \"17681138\", \"17592117\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Modeling lacks direct experimental perturbation of the delay\", \"How Id and Stat3 inputs integrate quantitatively not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstration that HES1 directly represses 5-HT1A and (later) GABAB1 receptor genes extended its repressor role to neurotransmitter-receptor programming.\",\n      \"evidence\": \"Promoter-reporter with consensus-site mutation, HES1-null receptor expression analysis, and ChIP at GABAB1 promoter with behavioral readouts\",\n      \"pmids\": [\"18499474\", \"35732696\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Behavioral consequences mechanistically indirect\", \"Allele-selectivity and receptor specificity incompletely generalized\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mapping GATA-1/Ikaros recruitment of NuRD and PRC2/EZH2 to the Hes1 locus revealed how HES1 itself is epigenetically silenced during lineage commitment.\",\n      \"evidence\": \"ChIP of GATA-1, FOG-1, MI-2, GFI1B, and EZH2 at the Hes1 locus in erythroid cells with EZH2 requirement assays\",\n      \"pmids\": [\"22778136\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this repressive module operates outside erythroid cells unknown\", \"Dynamics relative to oscillation not addressed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identifying deubiquitinase (Usp22/Usp27x/Usp51) control of HES1 stability connected protein turnover directly to oscillation period and differentiation timing.\",\n      \"evidence\": \"HES1 antibody pulldown for DUB purification, deubiquitination assays, Usp22 knockdown with half-life/oscillation measurement, and in vivo Usp27x misexpression\",\n      \"pmids\": [\"25846153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase(s) opposing these DUBs not identified here\", \"Tissue-specific DUB usage not mapped\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identifying HES1 repression of BBC3/PUMA and interaction with PARP1 showed HES1 contributes to leukemic survival and revealed a cell-type-specific cytotoxic vulnerability.\",\n      \"evidence\": \"HES1 knockdown with ChIP at BBC3 and apoptosis assays in T-ALL; reciprocal HES1-PARP1 Co-IP with NAD+/ATP/AIF readouts in B-ALL\",\n      \"pmids\": [\"25784680\", \"21224467\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Why PARP1 engagement is B-ALL-specific not fully explained\", \"BBC3 finding from single lab with knockdown only\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery of elongation-based (P-TEFb) repression at Cxcl1 and activator function inducing VEGF-C/WDFY1 established HES1 roles in restraining inflammation and innate immunity by non-canonical mechanisms.\",\n      \"evidence\": \"Hes1-null macrophages with ChIP for P-TEFb/Pol II Ser2; genome-wide ChIP-seq with VEGF-C/WDFY1 assays in infection and lupus models\",\n      \"pmids\": [\"27322654\", \"31015298\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HES1 switches between repressor and activator modes unresolved\", \"Direct vs indirect VEGF-C activation mechanism not fully dissected\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating direct HES1 repression of GADD34 linked HES1 to cytoprotection during ER stress.\",\n      \"evidence\": \"HES1 depletion with ChIP at GADD34 promoter and GADD34-dependent cell-death assays in mouse and human cells\",\n      \"pmids\": [\"29491143\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signal controlling HES1 during ER stress not defined\", \"Relationship to oscillation dynamics unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Live-imaging of oscillation dynamics in neural and muscle stem cells established the functional distinction between oscillatory and sustained HES1 in driving proliferation versus quiescence/differentiation.\",\n      \"evidence\": \"Hes1/Ascl1 and Hes1/MyoD reporter live imaging with conditional knockout and sustained overexpression in adult NSCs and muscle stem cells\",\n      \"pmids\": [\"30862661\", \"30862660\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular machinery sensing oscillatory vs sustained dynamics unknown\", \"How downstream effectors decode HES1 frequency unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showing KRAS/MAPK-ERK-driven sustained HES1 is required for ADM-to-PanIN progression, and that HES1 potentiates hedgehog signaling, expanded HES1 roles into oncogenic and ciliary contexts.\",\n      \"evidence\": \"Conditional Hes1 ablation in KrasG12D pancreatic models with lineage tracing; epithelial Hes1 knockout with ciliogenesis and Smoothened rescue in hair follicle stem cells\",\n      \"pmids\": [\"30705405\", \"31721388\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct HES1 targets driving PanIN progression not specified\", \"Mechanism of HES1 control over ciliary Smoothened accumulation unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defining HES1 control of HSC metabolism (PPARgamma/FAO) and the quantitative requirement for robust oscillation amplitude refined how HES1 enforces quiescence and proper neurogenic timing.\",\n      \"evidence\": \"Hes1 conditional knockout HSC transplantation with FAO/PPARgamma pharmacological rescue; type-1/type-2 oscillation knock-in alleles with brain morphometry and proliferation/apoptosis assays\",\n      \"pmids\": [\"32129527\", \"32094111\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct HES1 target in the PPARgamma/FAO axis not identified\", \"How amplitude is read out by progenitors unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying RASSF1A/SNURF-RNF4-mediated degradation and showing oscillation is specifically required for quiescence exit completed a stability-and-dynamics regulatory picture with tumor and stem-cell consequences.\",\n      \"evidence\": \"RASSF1A-HES1-SNURF/RNF4 Co-IP and ubiquitination assays with stability measurement; matched-level persistent vs oscillatory HES1 in BMP4-induced quiescent NSCs\",\n      \"pmids\": [\"34897944\", \"34703994\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How SUMO-targeted degradation integrates with DUB activity unresolved\", \"Quiescence-exit finding is single-lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identifying HES1 activator targets IGBP1/PP6 (in psoriasis) and MYEOV/SOX9-driven HES1 induction added activator functions and upstream transcriptional regulators in disease contexts.\",\n      \"evidence\": \"ChIP at IGBP1 promoter with PP6 ubiquitination and HES1 stability assays; MYEOV-SOX9 Co-IP and ChIP at HES1 enhancer with knockdown rescue\",\n      \"pmids\": [\"36535970\", \"32879444\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Determinants of HES1 activator vs repressor behavior unresolved\", \"Single-lab evidence for each axis\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Dissecting dynamics-dependent p21 control (Dusp7/p-Erk) and metabolic reprogramming via IGF2BP2/GLUT1 showed HES1 output depends on its expression mode and reaches into glycolytic metabolism.\",\n      \"evidence\": \"Oscillatory vs sustained Hes1 in NSCs with Dusp7/p-Erk/p21 readouts; HES1 ChIP at IGF2BP2 promoter with GLUT1 mRNA stability and glycolysis assays\",\n      \"pmids\": [\"37200191\", \"37957183\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality of the dynamics-dependent paradoxical p21 effect untested\", \"Metabolic axis demonstrated mainly in colorectal cancer cells\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how the molecular machinery distinguishes oscillatory from sustained HES1 and how HES1 switches between transcriptional repressor and activator modes at different loci.\",\n      \"evidence\": \"No discovery in the timeline defines the decoder of HES1 dynamics or the determinant of its repressor/activator choice\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No mechanism linking oscillation frequency/amplitude to target decoding\", \"No structural or cofactor basis explaining activator vs repressor switching\", \"Opposing E3 ligase/DUB balance across tissues incompletely mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 4, 6, 9, 12, 22, 23]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [6, 9, 11, 16, 19, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [15, 17, 39]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [9, 12, 22, 23]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 4, 10, 26]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [6, 9, 11, 12, 36]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [22, 23]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RBPJ\", \"HES6\", \"ID2\", \"PARP1\", \"RASSF1A\", \"RNF4\", \"USP22\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}